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ABSTRACT 
 
Mitochondria are vital organelles, critical for energy supply and cell survival.  Such 
functional versatility is paralleled by the structural complexity of the organelle. 
Mitochondria are dynamic and can continuously alter their morphology.  The 
movement of these organelles is controlled by their interaction with the cytoskeleton.  
To date, the morphology and movement of mitochondria in muscle has yet to be fully 
explored.  Thus, the overall purpose of this Dissertation was to: 1) examine the effects 
of chronic muscle use and disuse on mitochondrial morphology and regularity protein 
expression, 2) investigate the cytoskeletal filaments responsible for governing 
mitochondrial movement within skeletal muscle cells, and 3) elucidate the effects of 
oxidative stress on organelle moment and morphology. 
 The mitochondrial network within cells is mediated by opposing fission and 
fusion processes.  In Manuscript #1, we investigated the expression of the proteins 
responsible for these events during conditions of altered oxidative capacity within rat 
skeletal muscle.  The results demonstrate that chronic muscle use increases the ratio 
of fusion:fission proteins, leading to reticular mitochondria, whereas muscle disuse 
and aging result in a decrease in this ratio, culminating in a disruption of the 
mitochondrial network, and fragmented organelles. 
 Manuscript #2 focuses on determining the cytoskeletal elements that are 
primarily responsible for mitochondrial movements in muscle cells, and asks whether 
calcium can influence organelle motility.  Dynein and kinesins motor proteins use 
microtubules to transport cargo throughout the cell.  The ability of mitochondria to 
respond to calcium has previously been found to be mediated by motor 
protein/adaptor complexes in neurons.  Using live-cell imaging, we monitored 
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mitochondrial motility and found that they move primarily along microtubules tracks.  
Moreover, displacement of mitochondria is regulated by calcium, which inhibits 
organelle movements through the microtubule motor protein adapter, Milton.  By 
understanding the regulation of these movements we elucidated the underlying basis 
for organelle interactions that lead to the formation of the mitochondrial reticulum, 
and the distribution of energy in muscle cells. 
 The focus of Manuscript #3 was to determine whether mitochondrial dynamics 
are altered after an acute exposure to oxidative stress.  In addition, we elucidated the 
interplay between mitochondrial morphology and stress responses.  Mitochondrial 
stress is speculated to result in the activation of at least three cellular responses, 
including mitophagy, and the mitochondrial- and the ER-unfolded protein responses.  
We found that oxidative stress halts mitochondrial movement and induces 
mitochondrial fragmentation in myoblasts.  The observed oxidative stress-induced 
mitochondrial fragmentation is mediated by Drp1.  Moreover, we demonstrated that 
the unfolded protein responses are activated prior to the initiation of mitophagy during 
oxidative stress.   
 Collectively, our data illustrate that mitochondrial morphology is affected 
during conditions of chronic muscle use and disuse, and the movement of 
mitochondria in muscle cells is influenced by both oxidative stress and calcium 
signalling.  
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1.0  INTRODUCTION 
 
The maintenance of mitochondrial size depends on reaching an equilibrium between the 
fission and fusion states.  The fusion process involves the mixing of mitochondrial 
material, whereas the fission process divides the organelle into smaller components.  
Disruptions in either of these opposing processes can lead to developmental defects and 
disease (178), suggesting that proper maintenance  of  mitochondrial morphology is 
critical for normal cell function.  Skeletal muscle mitochondrial morphology has been 
demonstrated to be altered under various disease conditions, including diabetes (9; 82) 
and obesity (9; 10), as well as during development (11), aging (75), and exercise (87).  
Mitochondria are maintained in a dynamic state as a quality control mechanism.  
Mitochondrial fusion allows for the formation of a networked reticulum.  Fusion of 
mitochondria also enables complementation to occur, and acts as a cellular defence 
mechanism (123).  Two mitochondrial genomes are able to complement potential defects 
through inter-mitochondrial mixing, and can prevent the expression of disease 
phenotypes that may arise from mtDNA defects.  In addition to the advantages of an 
extended reticulum, some disadvantages may also exist.  If local damage was to occur 
within a portion of the mitochondria, it may be postulated that this damage would 
influence the entire reticulum; however mitochondrial fission is able to negate those 
potential detrimental effects.  Under detrimental conditions such as apoptosis, 
fragmented, smaller mitochondrial structures have been observed (45; 46; 77; 93).  
Moreover, recently it has been established that dysfunctional mitochondria have to be 
segregated and processed into smaller, fragmented components in order to be engulfed by 
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autophagosomes during autophagy (163).  These observations suggest that there may be a 
compensatory mechanism in place to isolate the damaged portion of the mitochondrial 
network from its unaffected parts. 
   Traditionally, mitochondria have been thought to be static in nature.  Modern 
imaging techniques reveal that these organelles are quite dynamic, capable of altering 
their shape and distribution within the cell. The location of these organelles within 
skeletal muscle is thought to influence the likelihood of a fusion or fission event 
occurring.  Positioning of mitochondria to specific sites within the cell is dependent on a 
cytoskeletal based transportation system.  In neurons, microtubules are the primary tracks 
governing mitochondrial movement in mammals.  However, the cytoskeletal system 
governing mitochondrial movement within skeletal muscle has yet to be examined. 
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2.0 MITOCHONDRIA 
In 1890 Altmann first characterized mitochondria based on their morphological 
resemblance to bacteria, and termed them “bioblasts” (6).  It was Carl Benda who 
described the structures and coined the name mitochondria (mito-tread, chondrion-
granule).  The morphology of these organelles began to be detailed in 1915 by Lewis and 
Lewis (95).  They noted that “in living cells these bodies are never quiet, but continually 
changing in shape, size, and position.”  
 
2.1. The geography of mitochondria in skeletal muscle 
 
In 1966, Gauthier and Padykula used electron microscopy to note the 
heterogeneity that exists in mitochondria within the diaphragm (53).  They described “a 
conspicuous feature…of large mitochondria beneath the sarcolemma…they are large and 
more or less spherical”.  Whereas, “the interior of the fiber, large mitochondria form 
chains running longitudinally among myofibrils” (53).  Bakeeva et al (12) and Kirkwood 
et al (86) expanded upon this knowledge of muscle mitochondrial morphologies by 
demonstrating the presence of a mitochondrial reticulum, akin to the sarcoplasmic 
reticulum, and representing a network of interconnected organelles.  Ogata and Yamasaki 
and Kayar et al provided further detailed characterizations of mitochondrial 
morphologies within muscle fibers possessing different oxidative capacities in the rat 
(118), horse (81) and human (119).  They noted the distinction between mitochondria 
localized in proximity to myonuclei and adjacent to the sarcolemma (subsarcolemmal 
(SS) mitochondria), as well as those situated between the myofibrils (intermyofibrillar 
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(IMF) mitochondria).  Historically, these morphological measurements using electron 
microscopy techniques allowed for the first evidence of structural and “geographical” 
heterogeneity within mitochondrial subfractions of muscle.  However, these studies also 
observed that the distinction between SS and IMF mitochondria was not absolute; 
continuity in the network could exist between the two subfactions, suggesting that one 
subfraction might arise from the synthesis of mitochondria in another region, and that 
processes of organelle fission, fusion and movement were likely to be important in 
determining mitochondrial location and morphology.  
 
 
2.1.1. Properties of SS and IMF mitochondria 
 
Adopting subcellular fractionation techniques first developed for heart muscle 
(124), Krieger et al (90) and Cogswell et al (34) separated the two mitochondrial 
subfractions and noted differences in mitochondrial respiration, enzyme activities, lipid 
composition, protein synthesis and adaptation to muscle use and disuse.  Thus, when 
isolated from muscle, these mitochondrial subfractions exhibit somewhat subtle, but 
distinct biochemical properties, which may parallel their divergent morphological 
characteristics.  SS mitochondria are located just below the sarcolemma, while IMF 
mitochondria are found between the myofibrils.  SS and IMF mitochondria possess 
distinctive biochemical properties.   In terms of respiration, IMF mitochondria exhibit a 
greater state 3 rate than SS mitochondria, and they possess greater cytochrome c oxidase 
activity (34).  Compositional differences among these subfractions exists in terms of 
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phospholipid content and protein-to-lipid ratios, as evident by the greater proportion of 
cardiolipin in SS relative to IMF mitochondria (34).  
Currently, it is unknown whether one subfraction is a precursor of the other, or 
whether SS and IMF mitochondria are actually physically interconnected.  Is it possible 
for continuous membrane networks within cells to possess divergent functional 
characteristics, given the fluidity of membrane bilayers?  Certainly this appears to be true 
at the neuromuscular junction, where specialized synaptic proteins are localized in 
distinction from the rest of the sarcolemma.  The interface between the lateral sac of the 
SR and the t-tubule is another example, where voltage-sensitive proteins promote the 
release of calcium, in contrast to the longitudinal portion of the SR where calcium uptake 
is favoured.  These situations provide evidence of protein heterogeneity within a 
continuous lipid bilayer.  It seems reasonable to assume that divergences could also exist 
within the mitochondrial network, particularly in view of the more “labile” nature of the 
SS subfraction in response to chronic muscle use or disuse, as well as their proximity to 
myonuclei in comparison to more continuous IMF mitochondria.  
 
2.2.  Existence of mitochondrial reticulum 
 
The distribution, volume and shape of mitochondria within muscle fibres are a 
reflection of the balance between the activities of mitochondria morphology proteins, 
possibly regulated by the requirement for metabolite transport, energy demand, and 
oxygen diffusion.  The beneficial aspects of a continuous membrane network would be 
apparent in instances where the energy requirement and substrates are not 
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homogeneously distributed within a fibre.  A reticular mitochondrial structure could 
rapidly compensate for any deficits, serving to maintain an electrical potential along the 
membranes for extended distances, and reducing diffusion times for lipid soluble 
metabolites and oxygen (12).  In contrast, the dismantling of the mitochondrial network 
into fragmented parts, as produced by chronic muscle disuse, likely decreases the 
efficiency of substrate transport, and produces mitochondria that are functionally 
heterogeneous with respect to membrane potential and mtDNA content. The loss of 
mitochondrial fusion results in a pathogenic profile in skeletal muscle, whereby mtDNA 
mutations are severely elevated (30).  Romanello et al (135) also found that increases in 
mitochondrial fragmentation contribute to muscle loss, and that the inhibition of 
organelle fission protects from muscle atrophy.  Disruptions in organelle dynamics have 
also been tied to obesity and type 2 diabetes (97).  These studies suggest that 
mitochondrial morphology is linked in the pathophysiology of various diseases.   
 
2.3.  Machinery involved in mitochondrial reticulum formation 
Changes in mitochondrial dynamics are regulated by opposing fusion and fission 
processes.  Fusion of smaller organelles promotes the intermixing of mitochondrial 
material and an expansion of the mitochondrial reticulum as a result of endurance 
training, an observation made by Kirkwood et al some years ago (87).   Fission, on the 
other hand, divides mitochondria into smaller pieces.  Essential mammalian skeletal 
muscle fusion proteins involved in these processes are displayed in Figure 1. 
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Figure 1: The maintenance of mitochondrial shape is dependent on reaching an 
equilibrium between the fission and fusion states.  The fusion process involves the 
mixing of mitochondrial material, whereas the fission process divides the organelle into 
smaller components.  Mitochondrial fusion is governed by the proteins Opa1 and Mfn1/2.  
Opa1 coordinates the fusion of the inner mitochondrial member (IMM).  Whereas, 
Mfn1/2 tethers adjacent organelles and brings them into close proximity to one another to 
allow for the fusion of the outer mitochondrial membranes (OMM).  Fission events are 
mediated by Fis1 and Drp1.  Fis1 resides on the OMM and Drp1 is found in the cytosol 
in a phosphorylated state.  During division, Drp1 is dephosphorylated and recruited to the 
mitochondrion.  Drp1 forms a ring-like structure around the organelle, constricts, and 
divides the mitochondrion. 
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Mitofusin 2 (Mfn2), which behaves as an anchor, bringing adjacent mitochondria into 
close enough proximity to fuse their outer membranes, as well as the inner mitochondrial 
membrane protein optical atrophy 1 (Opa1).  Mitochondrial membrane fission is 
mediated by dynamin related peptide 1 (Drp1), in combination with fission protein 1 
(Fis1).  Fis1 is involved in outer membrane fission, whereas Drp1 must be recruited from 
the cytosol to the outer surface of the organelle, whereupon it wraps around the 
constriction points of diving mitochondria to promote the division of organelles. 
 
2.3.1. Mfn2 
The double membrane nature of mitochondria makes it essential to consider both 
components when discussing mitochondrial morphology.  Inner and outer membrane 
fusion events within mitochondria are separable, and involve different morphology 
machinery proteins.   Outer member fusion is regulated by the mitofusions, Mfn1 and 
Mfn2 (134).  The mitofusions contain a GTP-binding domain, a transmembrane domain, 
two coiled-coil regions, upstream and downstream of the transmembrane domain, 
allowing for anchorage of the protein in the outer membrane (138).  The mitofusions 
have N- and C-terminal domains exposed towards the cytosol.  This topology implies that 
the hydrophobic domains span the outer membrane twice (134).  The mitofusions tether 
adjacent mitochondria through a dimeric anti-parallel coiled-coiled structure, either 
through homotypic (Mfn2-Mfn2) or heterotypic (Mfn1-Mfn2) means (89), thus allowing 
for adjacent organelles to be brought into close proximity to one another for a fusion 
event to occur.   
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Although structurally similar, the functional roles of the mitofusions are 
divergent.  Mfn2 is presumed to have mostly a regulatory role, while Mfn1 is mainly 
responsible for tethering adjacent mitochondria (76).  Moreover, Mfn1 can only promote 
mitochondrial fusion in the presence of Opa1, whereas Mfn2 can act independently (33).  
The expression patterns of the mitofusions are tissue specific, whereby Mfn2 is highly 
expressed in skeletal muscle as compared to Mfn1 (137).    
 
2.3.2. Opa1 
Inner mitochondrial membrane fusion is mediated by the dynamin-related protein, 
Opa1.  Opa1 is weakly anchored to the inner mitochondrial membrane, with the N-
terminus exposed to the matrix and the bulk of the C-terminal domain exposed to the 
intermembrane space (44; 122).  Mammalian Opa1 exists as eight isoforms as a result of 
alternative splicing and proteolytic processing (40), which may indicate functional 
diversity of the protein, however the differences in function and processing mechanisms 
have yet to be fully identified.  Separately, the Opa1 isoforms have little activity, but 
when coexpressed the long and short and isoforms functionally complement each other 
(44).  Furthermore, the yeast homologue, Mgm1, exists in two lengths, the large Mgm1 
(l-Mgm1) and the small isoform (s-Mgm1), and both forms are required for the proper 
maintenance of mitochondrial DNA and  morphology (67).   
Over-expression of Opa1 promotes an elongated mitochondrial reticulum, 
whereas knockdown of the protein results in fragmented organelles (33).  Blockage of the 
protein in mammalian cells eliminates all mitochondrial fusion, and results in poor cell 
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growth and decreased respiration (28).  In addition to its role in inner mitochondrial 
membrane fusion, Opa1 is also essential for mitochondrial cristae organization and 
function.  In cells devoid of the protein,  mitochondria exhibit disorganized cristae 
structures (121).  
 
2.3.3. Drp1 
Similar to mitochondrial fusion, the fission processes are also regulated by 
specific morphology proteins.  Mitochondrial fission was first observed as a process 
orchestrated by Drp1 (17; 148).  Drp1 belongs to a family of large GTPase of the 
dynamin family, possessing highly conserved N-terminal and a putative helical domains 
(148).   All dynamin members are structurally similar, but functionally diverse GTP-
binding proteins.  Drp1 polymerizes into a ring-like structure around mitochondria.  
Cross-bridging of the GTPase domains of adjacent Drp1 proteins results in GTP 
hydrolysis, constriction, and ultimately severing of mitochondria (152).  The 
phosphorylation status of Drp1 is an important determinant of its localization and effect 
on mitochondrial structure.  Phosphorylation of Drp1 at Ser
637
 results in inhibition of its 
GTPase activity and an inability of Drp1 to  translocate from the cytosol to the sites of 
mitochondrial division, resulting in an attenuation of mitochondrial fission (27; 35).  
Because Drp1 lacks a mitochondrial targeting sequence, it is thought that a protein(s) 
may be responsible for mediating the recruitment of Drp1 to mitochondria.  Whether or 
not the other well characterized fission protein, Fis1 is involved is still controversial.  
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The mechanisms by which Drp1 is regulated are only beginning to be established.    
Drp1 is modified post-translationally by protein phosphorylation, sumoylation and 
ubiquitylation.  As previously mentioned, dephosphorylation of Drp1 is required for the 
translocation and subsequent activation of Drp1.  Cyclic AMP-dependent protein kinase 
(PKA)-dependent phosphorylation of Drp1 at Ser
637
 results in inhibition of its GTPase 
activity and mitochondrial division (27; 35).  Additionally, in response to ATP depletion, 
de-phosphorylation of Drp1 at Ser
637
 is upregulated, but becomes re-phosphorylated 
when cells are returned to a high ATP environment, indicating that Drp1 phosphorylation 
is ATP-dependent (32).  ATP depletion results in Drp1 activation and contributes to 
mitochondrial fragmentation (32).  Moreover, it has been shown that calcineurin 
regulates Drp1 dephosphorylation, allowing for its translocation to mitochondria (25; 35).  
Knockdown of calcineurin results in an accumulation of P-Drp1 in the cytosol, 
coinciding with reduced Drp1 localization to mitochondria and attenuated mitochondrial 
fragmentation (169).   
Drp1 is expressed at the highest levels in the brain, followed by skeletal and 
cardiac muscles (148).  Depletion of Drp1 in HeLa cells leads to the loss of mtDNA, a 
decrease in mitochondrial respiration, coupled to an increase in the levels of cellular 
reactive oxygen species (125).  Moreover, inhibition of Drp1 prevents DNA 
fragmentation, indicative of reduced apoptotic cell death (46).  Therefore, these results 
suggest that mitochondrial fission is required to isolate damaged regions through 
fragmentation.
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 2.3.4. Fis1 
The C-terminal domain of Fis1 contains a single transmembrane domain that 
anchors the protein in the mitochondrial outer membrane, leaving the bulk of the protein 
exposed to the cytosol.  The N-terminal cytosolic domain contains six -helices that are 
responsible for the fission activity of Fis1 (43; 144; 157).  The transmembrane segment 
of Fis1 directs the import of the protein post-translationally from the cytosol into the 
outer membrane of mitochondria (83).   
Over-expression of Fis1 results in fragmented mitochondria, whereas the 
knockdown of the protein leads to an increase in organelle networks and interconnected 
mitochondria (151).  Taken together these findings propose that multiple members of the 
mitochondria fusion-fission machinery are involved in controlling mitochondrial 
morphology and that there is a complex interplay between the regulators. 
 
2.3.  Models of mitochondrial reticulum alterations in skeletal muscle 
Mitochondria are vital contributors not only to cellular life, but also to the death 
process.  Disruptions in mitochondrial dynamics can lead to developmental defects and 
diseases (178), suggesting that proper maintenance  of  mitochondrial morphology is 
critical for normal cell function.  Skeletal muscle mitochondrial morphology has been 
demonstrated to be altered under various disease conditions, such as diabetes (9; 82), and 
denervation (108),  as well as during development (11), aging (75), and exercise  (87; 
129).  
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 2.4.1. Alterations in mitochondria morphology with development and age  
Immediately following birth, a progressive increase in the formation of 
interconnected mitochondrial networks occurs (11).  During this phase of muscle 
development, mitochondria begin to take on the appearance of mature reticula. They 
begin to contain mitochondrial junctions with branched tubular networks (11).  It is 
speculated that mitochondrial fusion during this process is important for life, since mice 
deficient in Mfn2 experience severe placental disruptions development, and a 
homozygous Mfn2 deficiency is embryonic lethal (29).   
Mitochondrial dynamics are not only important during early development, but 
also during the aging process.  Age affects the size of mitochondria in skeletal muscle, 
with mitochondrial area being larger in infancy, and gradually becoming smaller with age 
in humans (79).  Poggi et al. found similar results in their humans study, whereby 
mitochondrial size and mitochondrial percentage per fibre area decreasing with age (132).  
We have also found that the SS mitochondrial content is reduced in senescent Fisher 344 
Brown Norway rats as compared to their younger counterparts (75).   
Aging is a multidimensional process that involves a decline in the ability of the 
muscle to adapt to stress, damage and disease.  A decline in muscle mass and strength are 
prominent features of aged skeletal muscle, a condition known as sarcopenia.  During 
aging  this decrease in muscle mass has been attributed to reductions in muscle fibre 
number and fibre atrophy (96).  Skeletal muscle mass is determined by the rate of muscle 
protein synthesis and breakdown.  A reduction in muscle mass may occur if degradation 
rates exceed synthesis, or conversely a decrease in muscle protein synthesis occurs.  With 
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advanced age, the synthesis of myosin heavy chain (MHC) declines in humans, and 
correlates with measures of muscle strength (15).  The age-related declines in MHC may 
indicate a compromised ability of muscle to remodel. 
Several mechanisms have been proposed that cause sarcopenia, including 
increased reactive oxygen species (ROS) and oxidative stress (26; 168), an accumulation 
of mitochondrial abnormalities such as mtDNA mutations (99; 168), as well as an 
increased susceptibility to apoptosis (26; 42).  The free radical theory of aging postulates 
that the accumulation of ROS  is a key determinant of an organism’s life span (64).  
Although the mechanisms by which ROS contributes to aging and reduced lifespan are 
still unclear, there is evidence that increased oxidative stress damages DNA, proteins, and 
lipids (14).  Oxidative stress can damage mtDNA and impair mitochondrial function, 
resulting in an accumulation of ROS and exacerbated intracellular ROS-induced damage.  
Moreover, mitochondria isolated from senescent skeletal muscle have shown an 
increased production of ROS, in addition to enhanced apoptotic susceptibility (26; 102).  
Increased ROS production can activate the apoptotic signaling cascade and cell death 
mechanisms.  In aged skeletal muscle, an enhanced susceptibility towards the opening of 
the mitochondrial permeability transition pore (mtPTP) has been demonstrated (26).  
Opening of the mtPTP leads to the release of pro-apoptotic proteins, such as cytochrome 
c and endonuclease G, both proteins are upregulated in aged rats compared to their 
younger counterparts and result in increased mitochondrial apoptotic susceptibility (26).   
The mutation rates in mtDNA are substantially higher than in nuclear DNA (167).  
This is due to the lack of protective histones and lower number of repair enzymes within 
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mitochondria.  Examination of 34-year old rhesus monkeys (99) and 36-month old rats 
(21; 66) revealed an age associated accumulation of ETC enzyme abnormalities and 
mtDNA mutations.   
 
2.4.2. Alterations in mitochondria morphology with denervation 
Similar to the effects of aging, chronic muscle disuse, induced through 
denervation, is a potent stimulus that reduces mitochondrial content in the muscle (3; 
108; 147).  The molecular basis mediating this alteration has been attributed to, at least in 
part, the decreased expression of nuclear genes encoding mitochondrial proteins (147), 
reductions in protein import (147), increased ROS production (117), and/or increased 
mitochondrially mediated cell death (3). 
Denervation occurs when the nerve supply to muscle is severed. Denervation can 
be achieved through mechanical means (i.e. surgical sectioning or crushing), chemical 
blocking (i.e. tetrodotoxin), or injury (113).  This condition results in the elimination of 
nerve-muscle communication.  A predominant feature of denervation is muscle atrophy 
and a loss of muscle strength (172).   Moreover, denervation can lead to changes in the 
ultrastructure of muscle, including alterations to the number and size of mitochondria, 
sarcomere disorganization, and myofibrillar disruptions (105).  Mitochondrial content, as 
well as protein levels within tissue are balanced between the rate of synthesis and 
degradation.  With denervation there is a decrease in mitochondrial biogenesis and 
enhanced mitochondrially mediated degradation through apoptosis (172).  Since 
mitochondria possess their own transcription and translational machinery, they have the 
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ability to synthesize a number of their own proteins.  However, the majority of 
mitochondrial proteins are nuclear encoded and are imported into the organelle, with 
denervation mitochondrial import machinery components and import rates are reduced 
(147).   As a result of denervation, mitochondrial enzyme activities of cytochrome c 
oxidase (COX), citrate synthase (CS), and succinate dehydrogenase (SDH) are attenuated 
(172).   Concomitantly, denervation results in coordinated decreases in the expression of 
the mitochondrially-encoded subunit III and nuclear-encoded subunit VIc components of 
COX (172) and contributes to the reduced COX activity observed under these conditions. 
The exact mechanisms governing the loss in muscle mass with denervation have 
yet to be fully elucidated, although there is increasing evidence suggesting an 
upregulation in the rate of muscle protein degradation and the activation of 
mitochondrially specific autophagy (termed mitophagy).  For this process to occur it is 
thought that mitochondria must first be processed into smaller, fragmented components in 
order to be engulfed by autophagosomes during the mitophagy process.  In diaphragm 
muscle following denervation, it has been observed that mitochondria are smaller in 
structure, in contrast to control muscle that contain long, reticular organelles (108).  
Mitochondrial fragmentation has been observed to occur following denervation, however, 
the link between the shape of the organelle and mitophagy still needs to be fully explored. 
   
2.4.3. Alterations in mitochondria morphology with mitochondrial biogenesis 
Skeletal muscle has the remarkable ability to adapt to increased metabolic 
demands, such as exercise, by increasing the size and number or mitochondria.  This 
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process is termed mitochondrial biogenesis and involves the coordination of both 
mitochondrial and nuclear genomes (72).  Changes in mitochondria biogenesis are due to 
multiple molecular events.  These pathways include the activation of signaling kinases, 
the induction of transcription factors, changes in mRNA stability, post-translational 
modifications, alterations in protein import rates, and/or the rate of protein folding (72).   
In response to exercise, the mRNA and protein expression of the transcriptional 
coactivator, PGC-1α, and transcription factors, such as mitochondrial transcription factor 
A (Tfam) are upregulated (5; 58; 91).  Activation of mitochondrial transcriptional factors 
regulates the expression of nuclear genes encoding mitochondrial proteins (NUGEMPs), 
as well as the transcription and mRNA expression of PGC-1α (73).  Moreover, PGC-1α 
binds to transcription factors and regulates the expression of NUGEMPs (130).  
Subsequently, the mRNA products are translated and imported through specialized 
import machinery into the organelle.  These proteins will either be used as transcription 
factors for mtDNA, or be integrated into the subunits of the electron transport chain (73).  
The coordination of both the nuclear and mitochondrial genomes allows for the 
expansion of the mitochondrial reticulum and alterations in the composition of the  
mitochondrion (70; 87). 
Chronic muscle use can be induced through a variety of models, including 
treadmill and voluntary wheel training, as well as chronic contractile activity (CCA).  
Chronic activity through these protocols can cause changes in the expression of 
mitochondrial proteins (72). Previous studies have demonstrated the effectiveness of 
CCA model for studying the phenotypic changes in skeletal muscle elicited by contractile 
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activity (159).  Chronic low-frequency indirect muscle stimulation has been shown to 
lead to alterations in mitochondrial gene expression and enzyme activities, in addition to 
an increased concentration of the mitochondrial phospholipid cardiolipin (158).     
The mitochondrial reticular network is known to expand as a result of endurance 
training  (87; 129).   Kirkwood et al originally demonstrated that mitochondria in skeletal 
muscle adapted to chronic exercise by increasing the extensiveness of the mitochondrial 
reticulum (87).   This suggests that chronic exercise shifts the expression of fission and 
fusion machinery towards that of enhanced fusion.   
The alterations in mitochondrial biogenesis are driven, in part, by PGC-1α, a 
major regulator of mitochondrial biogenesis (61).  Mice deficient in PGC-1α have a 
reduced expression of Mfn2 mRNA (177).  Conversely, an up-regulation in PGC-1α, 
from a single bout of cycling exercise, stimulated ERRα binding at the -413/-398 motifs 
on the Mfn2 promoter, resulting in an increase in Mfn2 mRNA during the recovery phase 
(24).  Similar observations were seen by Ding et al (41), whereby Mfn2 mRNA content 
increased during recovery from acute exercise.  Moreover, Garnier et al (52) also found a 
coordinate increase in mitochondrial biogenesis, specifically PGC-1α, and Mfn2 
transcriptional levels. 
 
2.4.4. Alterations in mitochondria morphology with diabetes 
Diabetes is defined as a group of metabolic disorders, characterized by abnormally 
elevated plasma glucose concentrations, due to insufficient insulin secretion or abnormal 
insulin response.  The most common form is Type 2 diabetes (T2D), and comprises of 
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approximately 90% of all diabetics cases around the world (1).  T2D is associated with 
insulin resistance, and high levels of blood glucose, also known as hyperglycemia.  
Following a meal, the concentration of glucose is elevated, which drives the insulin 
oscillations (57).  The increase in glucose post-meal, drives β-cell release of insulin (57).  
In the post-absorptive state the concentrations of glucose and insulin return to basal 
levels.   However, in T2D individuals, the uptake of glucose by insulin sensitive tissues is 
impaired.  Consequently, β-cells try to compensate for the insulin resistance by increasing 
insulin secretion, to little avail in the circulating glucose concentrations.  The 
maintenance of normal glucose homeostasis depends on a variety of tissues, such as 
skeletal muscle, a predominant site of insulin-mediated glucose uptake (38; 39).   
Moreover, the skeletal muscle of T2D patients display impaired mitochondrial 
functioning (82). 
Several mechanisms regulate the reduction in mitochondrial activity in insulin-
resistant patients, such as a reduction in mitochondrial content.  In this regard, 
mitochondria from the skeletal muscle of T2D patients have been found to be smaller in 
size than in muscle from lean individuals (82).   The size of mitochondria correlated with 
insulin sensitivity and glucose disposal rates (82).  Upon closer examination at the level 
of the proteins involved in mitochondrial morphology, a positive correlation was found 
between levels of Mfn2 expression and insulin sensitivity in T2D patients (9).  T2D 
patients display reduced Mfn2 mRNA levels, relative to their lean counterparts (9).  
Moreover, the repression of Mfn2 has been shown to reduce glucose oxidation (10).   
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2.5. Signaling pathways 
Skeletal muscle is highly malleable and responds by increasing or decreasing its 
mitochondrial content in response to physiological stimuli.  Major signaling transduction 
pathways involved in these adaptations include those initiated by 1) AMP-activated 
kinase (AMPK), 2) calcium, and/or 3) reactive oxygen species (ROS), as displayed in 
Figure 2. 
 
2.5.1. AMPK-activated protein kinase (AMPK) 
AMPK is a heterotrimer protein comprises of an α-catalytic subunit and βγ-
regulatory subunits.  Isoforms for all three subunits have been identified (α1, α2, β1, β2, 
γ1, γ2, and γ3) (150).  AMPK is a critical energy sensor in the cell that reacts to 
fluctuations in the AMP/ATP ratio.  AMPK is activated by the allosteric binding of AMP, 
in addition to the phosphorylation of Thr
172
 within its catalytic subunit by upstream 
kinases.  To date, three upstream mammalian kinases for AMPK have been identified, 1) 
liver kinase B1 (LKB1) (98), 2) calmodulin-dependent protein kinase kinase-beta 
(CAMKKβ) (173), 3) transforming growth factor-β-activated kinase-1 (Tak1 kinase) 
(176). 
AMPK is a metabolic sensor that can regulate the energy status of the cell.  Its 
activation represses many anabolic processes, such as triglyceride, cholesterol, fatty acid, 
and protein synthesis (150).   Conversely, AMPK stimulates several catabolic processes 
that generate ATP, such as fatty acid oxidation and glycolysis (150).  In response to 
exercise,  
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Figure 2:  Overview of major signaling pathways regulating mitochondrial content 
in skeletal muscle cells. Signals originating from the neuromuscular junction 
include propagating action potentials to the post-synaptic membrane.  As the 
action potential travels across the sarcolemma membrane, it causes the release of 
calcium (Ca2
+
) from the sarcoplasmic reticulum.  Calcium interacts with the 
contractile machinery to initiate muscle contractions.  Calcium also activates 
kinases such as Ca2
+
/calmodulin-dependent protein kinase (CaMK).  Furthermore, 
contractile activity breaks down adenine triphosphate (ATP) to produce adenine 
diphosphate (ADP), and subsequently adenine monophosphate (AMP).  Thus 
increasing the AMP/ADP to ATP ratio and activating AMP-dependent protein 
kinase (AMPK).  Moreover, mitochondria are the primary source of reactive 
oxygen species (ROS),  Elevated ROS levels can lead to a signaling cascade that 
can result in apoptosis.  CaMK, AMPK, and ROS signaling cascades regulate the 
transcription of nuclear genes encoding mitochondrial proteins.  These mRNAs are 
subsequently translated into proteins and imported into mitochondria, thus 
increasing mitochondrial activity and content. 
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skeletal muscle undergoes rapid ATP turnover.  Whereby, AMP and ADP levels increase 
with exercise, resulting in the activation of AMPK (51).  AMPK activation allows for 
ATP levels to remain relatively constant, despite the large fluctuations in energy 
demands.  
Once stimulated, AMPK phosphorylates downstream targets aimed at conserving 
existing ATP levels.  AMPK activation has been shown to induce the expression of PGC-
1α, GLUT4, and mitochondrial genes (78).  Furthermore, AMPK was found to directly 
phosphorylate PGC-1α, thus allowing for increased PGC-1α-dependent induction of the 
PGC-1α promoter (78).  Moreover, AMPK upregulates Sirtuin 1 (SIRT1) activity, 
resulting in the deacetylation and modulation of downstream SIRT1 targets, such as 
PGC-1α (23).  Although all the targets of AMPK have yet to be fully elucidated, AMPK 
activation appears to influence mitochondrial content through PGC-1α, a key regulatory 
protein in mitochondrial biogenesis. 
 
2.5.2. Calcium 
In response to stimuli such as muscular contractions, calcium (Ca
2+
) is released 
from the sarcoplasmic reticulum, increasing the concentration of cytosolic Ca
2+ 
and 
leading to the activation of Ca
2+
-induced kinases, such as calcium/calmodulin (CaM) 
kinases (CaMKs), and protein kinases C (PKC), in addition to the phosphatase 
calcineurin.  The ubiquitous Ca
2+
 sensor CaM serves as the primary intracellular receptor 
for Ca
2+
.  CaM is a small 148 amino acid protein, capable of binding Ca
2+
 ions at a 
stoichiometry of 4 to 1 (103).  Binding of Ca
2+
 to CaM produces a conformational change 
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allowing for its interaction with target enzymes (103).  The Ca
2+
 /CaM complex can bind 
to a variety of proteins, including CaMKs. 
The CaMK family consists of CaM-dependent protein kinase I (CaMKI), CaMKII 
and CaMKIV, as well as the CaMKK members.  CaMKII is the predominant isoform 
found within skeletal muscle (136).  CaMKII members (CaMKII-α, -β, -γ, -δ), are 
activated by Ca
2+
/CaM binding, in response to elevated [Ca
2+
]i.  Subsequently, this 
binding results in a conformational change of the protein, allowing for the exposure of 
the ATP- and substrate-binding sites in the catalytic domains, as well as Thr
287
 in the 
inhibitory domain.  Phosphorylation of Thr
287
 allows for an enhanced affinity for CaM 
(104).  After finally disassociating from CaM, the modified subunit remains partly active.  
This results in the autonomous (independent of Ca
2+
 /CaM) CaMKII activation and 
phosphorylation at Thr
287
 (136).  CaMKII activation occurs rapidly, and persists even 
when [Ca
2+
]i decreases and return to basal levels, thus propagating the Ca
2+
 response.  
Thus, autophosphorylation may be a mechanism in skeletal muscle to accelerate the 
activation of CaMKII with contractions. Calcium signaling regulates protein kinases, as 
well as the activity of transcription factors, such as the early growth response gene-1 
(Erg-1).  Calcium-induced activation of Erg-1 is thought to be involved in Ca
2+
-mediated 
signal leading to mitochondrial biogenesis (49). 
 During basal conditions, [Ca
2+
]i in isolated single muscle fibres is 30 – 50 nM 
(171).  In response to muscle contractions [Ca
2+
]i reach 100 nM to 2 μM (31; 171).  
Increases in Ca
2+
 levels within skeletal muscle can also be achieved through the addition 
of the Ca
2+
 ionophore A-23187, ionomycin, caffeine, or thapsigargin.  These treatments 
 25 
have been shown to increase [Ca
2+
]i and induce the expression of genes involved in 
mitochondrial biogenesis in skeletal muscle (47; 48).  Moreover, rises in [Ca
2+
]i,  through 
the activation of CaMKII, result in the increase of PGC-1α protein and mitochondrial 
biogenesis (174). 
 
2.5.3. Reactive oxygen species (ROS) 
Mitochondria are the primary source of ROS generation (36; 88).  Within these 
organelles, low levels of ROS are constantly produced during normal respiration when 
the oxygen consumed undergoes a one-electron reduction, at complexes I and III in the 
electron transport chain (16).  Approximately 2 – 5% of electrons in the electron transport 
chain are prematurely donated to oxygen during cellular respiration (18; 100), producing 
the free radical superoxide.  Superoxide is quickly transformed into hydrogen peroxide 
(H2O2) by superoxide dismutase (MnSOD).  Subsequently, H2O2 is reduced to water by 
glutathione peroxidase or catalase, or converted to the highly reactive hydroxyl radical 
(∙OH) in the presence of reduced iron or copper (22).  Mitochondria are not the only 
source of ROS within skeletal muscle.  Additional sources of ROS production  include 
phospholipase A2 (179), xanthine oxidase in the cytosol of skeletal muscle cells (56), and 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) located within 
the sarcoplasmic reticulum, transverse tubules, and the sarcolemma (128). 
ROS molecules were once considered as solely detrimental, causing damage to 
proteins, lipids, and DNA.  Indeed, ROS are involved in the pathogenesis of conditions 
such as inherited muscular dystrophy (112), denervation (3) and aging (26).  However, 
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accumulating evidence indicates that moderate levels of ROS have a positive role in 
skeletal muscle.  For example, ROS can have adaptive effects during muscle injury and 
repair (162).  Similarly, ROS generation during exercise promotes mitochondrial 
biogenesis through the expression of NRF-1 and PGC-1α (145; 156). 
 
2.6.  Mitochondrially-mediated apoptosis 
Apoptosis is the process of programmed cell death, it occurs when a cell is no 
longer required or damaged.  Ultrastructural features of apoptosis include DNA 
fragmentation, plasma membrane blebbing, loss of membrane integrity, cell shrinkage, 
and chromatin condensation (84).   The elimination of cells is a finely controlled process 
regulated by the activation of pro- and anti-apoptotic proteins.  Mitochondrial outer 
membrane permeability leads to the loss of mitochondrial membrane potential and allows 
for the release of apoptotic factors, such as cytochrome c to the cytosol.  Outer membrane 
permeability is regulated by the BCL-2 family of proteins.  Anti-apoptotic BCL-2 family 
members that help to maintain the integrity of the membrane include Bcl-2 and Bcl-xL 
(2).   Whereas pro-apoptotic BCL-2 proteins promote the release of cytochrome c include 
Bax, Bak and BH3-only proteins such as Bid and Bim (2).  The release of pro-apoptotic 
proteins from the mitochondria is facilitated by specialized pores, termed the mtPTP and 
the mitochondrial apoptosis-inducing channel (MAC).  MACs are composed of 
oligomerized Bax and/or Bak, and are localized to the outer membrane of mitochondria.    
The connection between mitochondrial fission and fusion processes and apoptosis 
is intriguing.  During apoptosis the mitochondrial network became fragmented in S. 
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Cerevisiae, C. elegans, COS-7 and HeLa cells (45; 46; 77; 93).  Perhaps compromised 
levels of mitochondrial fusion or enhanced levels of fission can potentially sensitize cells 
to apoptotic stimuli.  In support of these finding, an overexpression in fusion machinery 
components has been shown to inhibit apoptotic mitochondrial fragmentation, and delay 
Bax/Bak activation and cytochrome c release (155).  Conversely, downregulation of the 
fission machinery proteins prevents mitochondrial fragmentation, and reduces apoptotic 
cell death (46).  Moreover, Opa1 has been found to alter mitochondrial cristae junctions, 
thus allowing for the regulation of cytochrome c release during apoptosis (50; 92).   
 
2.7.  Autophagy 
Autophagy involves the sequestering of cytoplasmic material, its encapsulation and 
eventual digestion through delivery to the lysosome in response to stressful conditions, as 
a means of removal of damaged or superfluous organelles and proteins (60).  Autophagy 
can promote cell survival and maintain homeostasis, but it can also promote cell death 
through excessive self-digestion.  During general autophagy induction, the pro-autophagy 
proteins Beclin1, ULK1 and ATG7 initiate the formation of the autophagosome.  
Selective removal of dysfunctional mitochondria (i.e. mitophagy) is induced as a result of 
elevated mitochondrial ROS production (140), as well as the dissipation of the 
mitochondrial membrane potential (133; 163).  During this process, the cytosolic E3 
ubiquitin ligase, Parkin, is recruited to dysfunctional organelles with reduced membrane 
potential in a PINK1-dependent manner, thereby promoting mitophagy (115).  p62 binds 
to the ubiquitinated mitochondria, and acts as an adaptor for the organelles to be 
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recognized by the autophagic marker LC3 (120).  Subsequently, LC3II, a processed form 
of LC3, is localized in the membranes participating in the mitophagy process, and its 
content reflects the number of autophagosomes present in the tissue (80).  Upon 
encapsulation of the dysfunctional mitochondria, the autophagosome delivers this 
material to the lysosome for degradation, where lysosomal proteinases such as cathepsin 
D participate in their degradation (164).    
Mitochondrial morphology is closely integrated with mitophagy. For example, 
Parkin is an important component of the mitophagy process, and it also plays a critical 
role in modulating the morphology of mitochondria, such that inhibition of mitochondrial 
fission has been demonstrated to reduce Parkin-mediated mitophagy (160).  Moreover, 
Mfn1/2 are ubiquitinated in a PINK1/Parkin-dependent manner upon induction of 
mitophagy (54).   Therefore, the PINK1/Parkin pathway is thought to be the intermediate 
step between mitochondrial remodeling and mitophagy.  Mitophagy is dependent on the 
reduced fusion and the presence of fission, since Fis1 and Drp1 knockdown, and Opa1 
overexpression all reduce the levels of mitophagy (163).  For mitophagy to occur, 
dysfunctional organelles have to be segregated and processed into smaller, fragmented 
components in order to be engulfed by autophagosomes during the mitophagy process 
(163).  This alteration in mitochondrial shape involves fission and fusion machinery 
components. 
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2.8. Unfolded protein response 
The endoplasmic reticulum (ER) and mitochondria (mt) are exposed to newly 
synthesized protein and are responsible for their proper folding and assembly.  
Homeostasis is achieved by balancing the nascent protein load with the folding capacity 
of the organelle.  When the ability to do so is compromised, ER and mitochondrial stress 
ensues.  The adaptive responses to this imbalance, termed the ER-unfolded protein 
response (UPR) and mt-UPR, coincide with the upregulation of molecular chaperones 
allowing for the increased folding capacity of the cell.  If the cellular stress is too 
extensive and cannot be alleviated, the UPR activates cell destructive responses including  
apoptosis and the mitophagy pathway (127).   
ER stress triggers three ER transmembrane proteins, inositol requiring 1 (IRE1), 
double stranded RNA activated protein kinase (PKR)-like endoplasmic reticulum kinase 
(PERK), and activating transcription factor 6 (ATF6).  Once these stress sensors become 
activated they initiate the UPR by effecting downstream targets.  IRE1, PERK, and ATF6 
are maintained in an inactive state through interactions with the ER chaperone protein 
Binding Ig Protein (BiP).  In response to ER stress, PERK is liberated from BiP, thus 
allowing for its autophosphorylation and activation.  Subsequently, PERK phosphorylates 
eukaryotic initiation factor 2 (eIF2α), leading to inhibition of global protein translation 
(63; 143).   Additional downstream targets of PERK include C/EBP-homologous protein 
(CHOP) (62).  CHOP is a transcription factor that binds to and activates the promoter of 
stress response genes, such as c-Jun N-terminal Kinase (JNK) (74).  As such, CHOP is 
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capable of propagating the UPR signal.  Furthermore, it is also known that CHOP 
activates the transcription of mtUPR chaperone genes, such as mtHSP60 (127).   
In addition to the protective effects of the ER-UPR, the mechanisms governing 
the mitochondrial protein folded environment are beginning to be elucidated.  The 
majority of mitochondrially-destined proteins are encoded by nucleus and imported into 
the mitochondria in an unfolded state.  Failure of these proteins to fold properly can result 
in ROS accumulation (13).  ROS generation, in response to mitochondrially-specific 
stress activates general control nonrepressed 2 (GCN2), which phosphorylates eIF2α to 
reduce general translation of proteins (13).  A complementary pathway to that of GCN-2 
and eIF2α, involves transcription factor associated with stress–1 (ATFS-1), which 
upregulates mitochondrial chaperones to offset the accumulation of unfolded proteins 
(13; 116).  Recent microarray experiments from Nargund et al have found that 
mitochondrial fission genes are involved in the mtUPR in C. elegans (116), however 
more work is required to better understand its influence on mitochondrial morphology.    
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3.0 CYTOSKELETON 
Mitochondria are vital organelles, critical for energy supply and cell survival.  Such 
functional versatility is paralleled by the structural complexity of the organelle.  
Mitochondria can compensate for alterations in energy requirements by adjusting their 
size and distribution within skeletal muscle (37).  It is their interaction with the 
cytoskeleton that is used to control their position, movement and anchorage within cells 
(161).  As displayed in Figure 3, the three cytoskeletal elements, actin, microtubules and 
intermediate filaments act to vary the degree of scaffolding along which mitochondria are 
capable of moving. 
 
 
3.1. Microtubules 
 
Microtubules are used to support intracellular transport and cell organization.  
They are long rigid filaments, approximately 25 nm in diameter.  Microtubules are 
composed of α- and β-tubulin subunits, that link together in a heterodimer arrangement.  
Growth of microtubules occurs by the addition of these GTP-tubulin dimers.  During the 
addition of tubulin to the microtubule ends, the energy provided by the hydrolysis of 
tubulin bound GTP initiates a conformational change, resulting in the dynamic instability 
of the filament (109).  Dynamic instability allows for a plus-end, where the net addition 
of α/β-tubulin dimers occurs, and a depolymerizing minus-end, where there is a net loss 
of the tubulin dimers.  The growing plus-ends radiate out from the centre of the cell 
towards the periphery, whereas the minus-ends are located in the cell centre.  The 
movement of motor proteins along microtubules takes advantage of the dynamic  
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Figure 3: Pictorial representation of mitochondrial movement within the cell, as 
governed by cytoskeletal elements.  Actin, microtubules, and intermediate 
filaments constitute the cellular cytoskeleton, whereas dynein and kinesin are the 
motor proteins for microtubules.  Mitochondrial movement towards the nucleus is 
mainly governed by dynein, whereas motility away from the nucleus is 
predominately regulated by kinesins.  Myosin motor protein direct movement 
along actin. 
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instability of the tubulin polymer.  Growth of microtubules allows for the continued 
expansion of the cytoskeleton.  Conversely, the ability of microtubules to shrink is 
thought to be important for morphological changes in the cell, and in the reorientation of 
microtubules during the locomotion of organelles (109; 110).   
 
 
 
3.1.1. Kinesin motor protein 
 
Intracellular transport of cargo, such as mitochondria, to specific locations within the 
cell involves molecular motors that bind directly to cargo, such as mitochondria, and the 
cytoskeletal track.  Dynein and kinesins are the motor proteins responsible for motility 
along microtubules.  In neurons, movement along microtubules occurs either towards the 
cell body using cytoplasmic dynein, or away, using kinesins.  There are 14 kinesin 
superfamilies encoded by the human and mouse genomes, consisting of more than 45 
members (68; 107).  Molecular motors convert the chemical energy derived from the 
hydrolysis of ATP into mechanical energy.  Kinesin molecules move in discrete 8 nm 
steps along microtubules (141).  The kinesins motor protein is composed of a catalytic 
core domain, also termed the “head”, followed by the stalk region, and finally the “tail” 
domain.  The catalytic core contains the ATP- and microtubule-binding motifs, and is 
responsible for the movement generated by the hydrolysis of ATP (106).  This domain is 
conserved among kinesins, since they move across microtubules in a similar manner, 
however the stalk and tail domains are highly divergent, allowing for specification during 
cargo selection.   
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In neurons, Kinesin-1 and Kinesin-3 have been identified to regulate mitochondrial 
movements (114; 131).  Kinesin-1, also known as conventional kinesin, consists of three 
distinct members, Kif5A, Kif5B and Kif5C.  Kif5A and Kif5C are neuron-specific, 
whereas Kif5B is ubiquitously expressed (4; 8).  Inhibition of Kinesin-1 in Drosophila 
halts mitochondrial movement and alters mitochondrial positioning in motor axons (131), 
and in non-neuronal cells (161; 175).   
 
3.1.1.1.  Milton-Miro adaptor complex 
 
Recently, adaptor proteins that respond to intracellular signals are beginning to be 
identified.  Motor protein/adaptor complexes can mediate the transport of mitochondria in 
response to Ca
2+
.  The core of this complex is composed of the Kinesin-1 motor protein 
along with two mitochondrial-specific adaptors, mitochondrial Rho GTPase (Miro) and 
Milton (170).  Milton binds directly to Kinesin-1 (149), whereas Miro serves as an anchor 
linking Milton and Kinesin-1 to mitochondria (55).  The Milton-Miro complex has been 
recognized in Drosophila (19), rats and humans (20).  Mutations in either Miro or Milton 
result in disruptions to mitochondrial distribution in Drosophila (55; 59).  Miro and 
Milton proteins are also involved in Ca
2+
-dependent mitochondrial movement along 
microtubules (101; 170).  Elevated Ca
2+
 binds to the EF hands of Miro inducing a 
conformational change in the protein and allowing for its dissociation from microtubules, 
thus arresting mitochondrial movements (101; 170).    
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3.1.2. Dynein motor protein 
Cytoplasmic dynein is another microtubule-based motor protein that governs 
organelle movement towards the direction of the centre of the cell.  The dynein complex 
is composed of a carboxy-terminal motor “head” domain, consisting of a microtubule 
binding domain and an ATPase domain, which powers motility along microtubules, an 
amino-terminal tail domain, which consists of several noncatalytic subunits, and a linker 
region connecting the head and tail regions.  The amino-terminal domain of dynein 
homodimerizes and acts as the scaffolding for the assembly of the noncatalytic subunits 
which regulate dynein motility.  One of the subunits of the tail domain is dynactin.  
Dynein and dynactin form a multi-subunit complex that direct movement along 
microtubules towards the cell centre (85).  Although dynein alone can generate force and 
move along microtubules, it cannot bind to cargo on its own and requires dynactin as a 
linker between dynein and its cargo (85; 94).  The dynactin complex is composed of 
eleven different subunits, the largest ones being the actin related protein (Arp1) polymer, 
and p150
Glued
 (71; 139).  p150
Glued
 binds directly to microtubules and dynein, and allows 
for proper transport of cargo throughout the cell (85). 
 
3.2.  Actin 
 
Microfilaments, also known as actin filaments, are composed of actin monomers 
and average 8 nm in diameter (142).  The globular actin (G-actin) monomers polymerize 
to form filamentous actin (F-actin).  Two filaments twist to form helical actin.  Actin has 
a fast growing end, where there is a net addition of subunits, and a slow growing end, 
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with a net loss of actin subunits.  G-actin monomers are added to the growing filament 
end as ATP-actin.  ATP bound to actin is dephosphorylated to ADP during 
polymerization (153).  ADP and phosphate (Pi) both remain bound to actin, and after a 
long delay Pi is released, resulting in ADP bound actin (166).  The regulation of actin 
growth is determined not only by assembly and depolymerization steps, but also by 
branching and capping events.  Actin filaments alternate between capped and uncapped 
states.  Capping is important because it inhibits the disassembly of actin (166).  
Furthermore, cross-linking of actin filaments is regulated primarily by the actin related 
protein (Arp2/3) complex.  The Arp2/3 complex binds to the side of existing actin 
filaments and initiates the polymerization of a new actin branch (166).  
 Mammals possess at least six isoforms of actin.  Four muscle actins have been 
identified: α-skeletal, α-cardiac, α-smooth, and γ-smooth muscle actins, all have very 
similar structures (165).  Two cytoplasmic cytoskeletal actins (β- and γ-non-muscle) have 
also been found (165). 
In S. cerevisiae the positioning of mitochondria is reliant on actin-based 
transportation (146).  Furthermore, in cultured neurons, mitochondria use both 
microtubules and actin filaments for transport, although the motile behaviour of 
mitochondria are different between the two cytoskeletal filaments.  Whereby movement 
across actin occurs slower than along microtubules (111).    
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3.2.1. Myosin motor proteins 
Myosin motor proteins use actin filaments to transport cargo throughout the cell.  
To date, very limited work has been done to determine the role of myosin motors in 
regulating mitochondrial movement along actin.  The best candidates for mitochondrial 
movement are members of the myosin I, II, V, and VI families, as these motor proteins 
have been associated with movement of a variety of organelles (69).  Myosin V has been 
shown to play a role in mitochondrial movement in budding yeast (7).  Pathak et al found 
that mitochondrial motility away from the cell body was disrupted by myosin V, while 
movement towards the cell body was altered by both myosin V and VI (126).   
 
3.3. Intermediate filaments 
 
Intermediate filaments are flexible structures, ranging from 10-12 nm in diameter 
(154).  They are primarily used as structural support within animal cytoplasm and nuclei.  
There are five different categories of intermediate filaments, four are cytosolic and one is 
located in the nucleus (65).  To date there is no known motor proteins for intermediate 
filaments and they not thought to be involved in organelle movement. 
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4.0  PURPOSES: 
Based on the literature review, we have designed experiments with the following 
purposes in mind: 
1. To determine how mitochondrial morphology is altered during muscle use 
and disuse. 
2. To determine which cytoskeletal components are primary responsible for 
mitochondrial movement in muscle cells; 
3. To investigate the influence of calcium and ROS signaling on 
mitochondrial dynamics in myoblasts. 
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Rationale for Manuscript #1 
Skeletal muscle is characterized by its high mitochondrial content and its ability 
to adapt to metabolic stressors.  Under conditions of chronic muscle use or disuse the 
content and morphology of mitochondria is known to be altered.  The mitochondrial 
network within cells is mediated by fission and fusion processes.  We investigated the 
expression of the proteins responsible for these events during conditions of altered 
oxidative capacity. 
We hypothesized that chronic activity would induce alterations in the expression 
of mitochondrial fission and fusion machineries, and that fusion protein expression would 
outweigh the expression of fission machinery components.  Conversely, during 
conditions of chronic muscle disuse (aging, denervation), we hypothesized that the 
expression of mitochondrial fission proteins would be enhanced as compared to the 
fusion proteins. 
SI and DAH conceived and designed the experiments, interpreted the data and 
wrote the manuscript.  SI performed all of the data collection, except for some of the 
western blots towards the aging portion of the study, which were performed by AMJ.  
OO performed the in vivo stimulation of the animals and the COX activity measurements.  
KS performed the denervation surgeries.  
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Abstract 
INTRODUCTION: The mitochondrial network within cells is mediated by fission and 
fusion processes.  We investigated the expression of the proteins responsible for these 
events during conditions of altered oxidative capacity.  RESULTS: With chronic 
contractile activity, the mitochondrial reticulum increased in size, along with concomitant 
increases in the fusion proteins Opa1 and Mfn2 (by 36% and 53%, p<0.05).  When we 
induced muscle disuse through denervation for 7-days, fragmented mitochondria were 
observed, along with significant decreases in the expression of Mfn2 and Opa1 (by 84% 
and 70%).  To assess the effects of aging on mitochondrial morphology, young (5 month) 
and aged (35 month) Fisher344 Brown Norway rats were used.  Aged animals also 
possessed smaller mitochondria and displayed increased levels of fission proteins.  
CONCLUSIONS: Chronic muscle use increases the ratio of fusion:fission proteins, 
leading to reticular mitochondria, whereas muscle disuse and aging result in a decrease in 
this ratio, culminating in fragmented organelles. 
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Introduction 
Skeletal muscle is characterized by its high mitochondrial content and its ability to adapt 
to metabolic stressors.  Under conditions of chronic muscle use or disuse, this adaptation 
process involves coordination of several physiological events such as oxygen delivery, 
substrate utilization, capillary to muscle fiber ratio, and mitochondrial biogenesis.  
Although these alterations have been well studied, the effects of muscle use and disuse on 
mitochondrial morphology and the mechanisms governing the formation of these 
organelles has yet to be fully established. 
In skeletal muscle, mitochondria have been found to exist in varying 
morphologies, ranging from small individual organelles, to extended reticular networks.  
Mitochondrial morphology is altered during muscle development (6) and in various 
disease conditions, including diabetes (4; 26) and obesity (4; 5).  These changes in 
morphology are mediated by a balance of organelle fusion and fission events.  The 
double membrane nature of the mitochondria makes it vital to consider both the inner and 
outer membranes during mitochondrial fusion.  Essential mammalian skeletal muscle 
fusion proteins involved in these processes include mitofusin 2 (Mfn2), which is 
necessary for outer membrane fusion, and the inner mitochondrial membrane protein 
optical atrophy 1 (Opa1) (10; 31).  Mitochondrial membrane fission is mediated by 
dynamin related peptide 1 (Drp1), in combination with fission protein 1 (Fis1) (17; 23). 
Fis1 regulates outer membrane fission, whereas Drp1 lacks a mitochondrial targeting 
sequence and must be recruited from the cytosol to the outer surface of the organelle, 
where it participates in organelle division (29).   Disruptions in these key proteins have 
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been associated with neurological conditions such as Charcot-Marie-Tooth type 2A, and 
Parkinson, Alzheimer, and Huntington Diseases.  In several disease models, the 
alterations of mitochondrial fission and fusion proteins are associated with disease 
phenotypes (41). 
The distribution and volume of mitochondria within muscle fibers is thought to 
reflect a balance between the distance required for metabolite and oxygen diffusion from 
capillaries to the mitochondria (24) and the energy supply from mitochondria to 
myofibrils.  The mitochondrial reticulum likely serves as a system for the transport of 
lipid-soluble substrates and oxygen while maintaining an electrical potential along the 
membranes over extended distances (7).  Altering membrane topology has been shown to 
change the rate of metabolite transport and organelle function (11).  Evidence of such a 
relationship between mitochondrial function and morphology has been demonstrated 
under conditions where mitochondrial ATP synthase and the electron transport chain 
were inhibited (14).  Inhibition of these key components resulted in a dismantling of the 
mitochondrial network, with the organelle becoming smaller and more punctate in shape 
(14).  Upon removal of these inhibitors, the mitochondria resumed their elongated 
reticular structure (14).  In addition, during apoptosis the mitochondrial network becomes 
fragmented (16; 17; 22; 29).  Inhibition of fission proteins such as Drp1 or Fis1 has been 
shown to prevent mitochondrial fragmentation and reduce apoptotic cell death (17).  
These results support the idea that mitochondrial function is tied to morphology. 
Kirkwood et al originally demonstrated that mitochondria in skeletal muscle 
adapted to chronic exercise by increasing the extensiveness of the mitochondrial 
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reticulum (27).  In contrast, chronic muscle disuse, induced through denervation, has 
been shown to reduce mitochondrial content and organelle size (2; 32).  Similar results 
have been observed with age, whereby mitochondrial volume density decreases with age 
without a change in organelle number (34), reflecting greater mitochondrial 
fragmentation.  These studies demonstrate that mitochondrial morphology is altered 
during conditions of muscle use and disuse, a process governed by fission and fusion 
machinery.  The purpose of this study was to provide a descriptive evaluation of 
mitochondrial morphology in muscle of varying oxidative capacities in response to 
changes in organelle biogenesis.  Our study provides the necessary foundation to warrant 
further investigations on the molecular and regulatory aspects of fission and fusion 
proteins within muscle of differing oxidative capacities.  
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Experimental Procedures 
Animals and surgeries 
Fiber Types:  Normal male Sprague-Dawley rats aged 3-months were used.  The 
soleus, red gastrocnemius and quadriceps, and white gastrocnemius and quadriceps 
muscles were used as representative slow-twitch red, fast-twitch red, and fast-twitch 
white muscles, respectively.  Whole muscle extracts were prepared for all fiber types. 
Chronic Contractile Activity (CCA): Male Sprague-Dawley rats (Charles River, 
St. Comstant, Quebec, Canada) aged 6-months were used for the stimulation studies. The 
stimulation protocol was approved by the York University Animal Care Committee, in 
accordance with the Canadian Council on Animal Care as described previously (38).  
Briefly, a portable stimulator unit was fastened to the back of the animals with cloth tape.  
Under aseptic conditions, the electrodes from the stimulator unit were passed 
subcutaneously from the back of the neck to the thigh and sutured to either side of the 
common fibular nerve that innervates the tibialis anterior (TA) and extensor digitorum 
longus (EDL) muscles.  The skin was stapled, sterile ampicillin was injected to minimize 
the risk of infection, and the animals were allowed to recover for 7-days.  The TA and 
EDL muscles were subjected to electrical stimulation (10Hz, 3 hrs/day for 7 days), while 
the contralateral limb served as the non-stimulated internal control.  Whole muscle 
extracts, as well as subsarcolemmal (SS) mitochondria and cytosolic fractions were 
prepared. 
Denervation:  Denervation surgery was conducted as described previously (2) and 
approved by the York University Animal Care Committee in accordance with Canadian 
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Council of Animal Care guidelines.  Briefly, to induce unilateral denervation of the TA 
and EDL muscles of male Sprague-Dawley rats (6-months of age), a small portion of the 
common fibular nerve was excised from 1 limb of the animals while under anesthetic, 
and the contralateral limb served as the internal control.  The animals underwent 
denervation for 7-days, followed by tissue removal, as well as SS mitochondria and 
cytosole isolations 
Aging: Male Fischer 344 Brown Norway rats aged 5-months and 35-months were 
obtained from the National Institute of Aging (Bethesda, MD, USA). The Fisher 344 
Brown Norway rats are a well established animal model of aging due to their longer 
maximal life span and increased period of time pathology-free (30).  The animals were 
provided food and water ad libitum.   The TA and EDL muscles from the animals were 
excised and used for analysis.   
Tissue extraction and mitochondrial isolation 
Following muscle excision, the TA muscles were trimmed of excessive fat and 
connective tissue, minced thoroughly, homogenized briefly, and subjected to differential 
centrifugation as described previously (13) to fractionate subsarcolemmal (SS) 
mitochondria and cytosole extracts.  We chose the SS mitochondrial subfraction for 
protein analyses, because they represent the most labile pool of organelles in response to 
muscle use and disuse (1).  The EDL muscles were clamp frozen in liquid nitrogen 
following excision from the animals.  These samples were used to assess whole muscle 
levels of mitochondrial morphology machinery and COX activity.  The EDL muscles 
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from Fisher 344 Brown Norway rats were used for EM analyses.  Protein concentrations 
of the samples were determined using the Bradford method.  
Enzyme activities 
Cytochrome c oxidase (COX) activity was measured in EDL muscle samples as 
previously described (42), by determining the maximal rate of oxidation of fully reduced 
cytochrome c by measuring the change in absorbance at 550 nm in a multidetection 
microplate reader (Synergy HT; Bio-Tek Instruments, Winooski, VT, USA) at 30
o
C. 
Immunoblotting 
Whole muscle homogenates, isolated SS mitochondria, and cytosolic protein extracts 
were prepared from TA muscles as described above.  Protein extracts were separated 
using 10-15% SDS-PAGE and subsequently transferred onto nitrocellulose membranes. 
Membranes were then blocked (1 or 1.5 hr) with a solution of 5% skim milk in 1x TBS-
Tween20 (Tris-buffered saline–Tween-20: 25 mM Tris–HCl, pH 7.5, 1 mM NaCl and 
0.1% Tween-20) at room temperature, followed by incubation in blocking solution with 
antibodies directed towards Fis1 (1:500; Alexis Biochemical), Drp1 (1:500, BD 
Transduction Laboratories), Opa1 (1:500; BD Transduction Laboratories), Mfn2 (1:250; 
Sigma), Aciculin (1:200; DSHB University of Iowa), Porin (1:3000; Abcam), and 
GAPDH (1:20,000; Abcam) overnight at 4°C.  Samples were corrected for loading using 
GAPDH and Porin, for cytosolic and SS mitochondrial fractions, respectively.  Aciculin 
was used as the loading control for whole muscle tissue.  Following incubation with the 
primary antibodies, membranes were washed 3x 5-min with TBS-Tween20, followed by 
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incubation at room temperature (1 hr) with the appropriate secondary antibody 
conjugated to horseradish peroxidase and washed again 3x  5-min each with TBS-
Tween20.  Membranes were developed using Western Blot Luminol Reagent (Santa Cruz 
Biotechnology), and films were subsequently scanned and quantified via densitometric 
analysis of signal intensity with SigmaScanPro software (version 5, Jandel Scientific, San 
Rafael, CA, USA).   
 
Transmission Electron Microscopy 
Samples from the EDL muscles of young control, young stimulated, young denervated 
and aged Fisher 344 Brown Norway rats were prepared and analyzed as previously 
described (20).  Briefly, muscle samples were incubated on ice in 3% glutaraldehyde 
buffered with 0.1 M sodium cacodylate for 1 hr.  Muscle sections were then washed 3 x 
15-min with 0.1 M sodium cacodylate, followed by incubation in 1% osmium tetroxide in 
0.1 M sodium cacodylate at room temperature. After sections were fixed for proteins and 
lipids, samples were subjected to gradient dehydration of 30%, 50%, 80% and 100% 
anhydrous ethanol. Next, sections were embedded in a 1:1 solution of fresh Spurr 
embedding resin and anhydrous ethanol overnight.  Groups of muscle fibers were then 
dissected from the sections and embedded in fresh Spurr embedding resin and incubated 
at 60
°
C for 48 hrs.  Ultrathin sections (60 nm) were cut, placed on copper grids, and post-
stained with uranyl acetate and lead citrate.  Electron micrographs were imaged on a 
Philips EM201 electron microscope (FEI, Hillsboro, OR, USA). 
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The average area of individual intermyofibrillar (IMF) mitochondria and maximal 
SS depth were assessed based on EM images taken at 20, 000 – 45, 000X magnifications.  
In order to determine the maximal depth of SS mitochondria, a line was drawn from the 
outer edge of the most peripheral mitochondria to the edge of the myofibril.  The line was 
placed perpendicular to the myofibril.  The maximal distance between the mitochondria 
and myofibril was chosen in each case.   
Statistical Analyses 
Data were analyzed with GraphPad 4.0 software and expressed as means ± SE. Where 
appropriate, paired t-tests and one-way analyses of variance (ANOVA) were performed, 
followed by the Bonferroni post hoc test.  Differences were considered statistically 
significant if P < 0.05. 
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Results 
Expression of mitochondrial morphology proteins and cytochrome c oxidase (COX) 
activity in muscle fiber types.  COX activity was significantly greater in slow-twitch red 
(STR) and fast-twitch red (FTR) muscle by 1.9-fold and 2.7-fold, respectively, compared 
with fast-twitch white muscle (FTW) (Fig. 1A).  These findings are similar to other 
assessments of mitochondrial enzyme activity within low- and high-oxidative skeletal 
muscle fibers (3).  Representative immunoblots of Fis1, Drp1, Opa1, and Mfn2, key 
mitochondrial morphology proteins are shown in Fig. 1B.  Quantification of repeated 
experiments revealed that FTW fibers possessed the lowest protein expression of Fis1, 
Drp1, Opa1, and Mfn2.  The expression of Fis1 was identical in both STR and FTR 
fibers, and was 2.4-fold greater than in FTW whole muscle extracts.  The fission protein 
Drp1 was greatest in the STR fibers, followed by FTR fibers, and these values were 1.7 – 
2-fold greater than levels found in FTW.  The fusion proteins Opa1 and Mfn2 also 
displayed the greatest level of expression in the highly oxidative STR and FTR fibers. 
Both of these proteins were 1.5 – 2.1-fold (P<0.05) greater in STR and FTR muscle, 
compared with FTW muscle sections.   
 
CCA-induced alterations in mitochondrial content and morphology:  Transmission 
electron microscopy (TEM) analysis allowed us to assess changes in mitochondrial 
content and morphology in response to CCA (Fig. 2B), denervation (Fig. 2C) and aging 
(Fig. 2D) in skeletal muscle of Fisher 344 Brown Norway rats.  Animals subjected to 
chronic contractile activity (Fig. 2B) displayed increased thickness of the SS 
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mitochondrial layer by 58% (p<0.05), as compared to young control animals (Fig. 2A).  
Additionally, following CCA, individual IMF mitochondria were 75% larger (Fig. 2F) 
and appeared to be more reticular (Fig. 2B) than in the young control animals (Fig. 2A).  
This was accompanied by an approximately 30% increase in COX enzyme activity (Fig. 
3A), indicative of an increase in mitochondrial content.  This increase with CCA is in line 
with observations previously reported from our laboratory (1).  Within isolated SS 
mitochondria, expression of the fusion proteins Opa1 and Mfn2 increased significantly by 
36% and 53%, respectively (Fig. 3B).  Expression of the fission protein Drp1 decreased 
by 13% (P<0.05), whereas no significant difference was detected for Fis1.  Whole muscle 
levels reflected a similar pattern (data not shown).  Thus, these data suggest that CCA 
favors the expression and localization of fusion, rather than fission proteins.  
 
Expression of mitochondrial remodeling proteins and mitochondrial morphology as a 
result of denervation:  Transmission electron microscopy revealed that muscle subjected 
to denervation displayed a 64% reduction in the SS mitochondrial layer (Figs. 2C, 2E).  
The IMF mitochondrial network appeared to be sparse.  IMF mitochondria tended to be 
smaller and more fragmented in size as compared to those organelles in muscle of young 
control animals (Figs. 2A, 2F).  Similar to results previously reported with 7-days of 
denervation by our laboratory, (42) COX activity was reduced by 35% compared to the 
contralateral control muscle (Fig. 4A).  In the SS mitochondrial and cytosolic 
subfractions we observed dramatic decreases in the fusion proteins Opa1 and Mfn2 by 
84% and 70%, respectively (Fig. 4B).  In contrast, we observed a more moderate decline 
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of Fis1 by 46% in mitochondrial fraction from denervated muscle, while no difference 
existed for Drp1.  These observations suggest that denervation downregulates the fusion 
proteins to a greater extent than the fission proteins.  
 
Effect of aging on mitochondrial morphology proteins and COX activity:  We observed a 
46% decrease in the thickness of the SS mitochondrial layer, disruptions in the 
distribution of normal  IMF mitochondria, and a 37% (P<0.05) reduction in the size of 
individual IMF mitochondria (Figs. 2D, 2E, 2F) with age.  The mitochondria were 
distributed irregularly among the myofibrils, and disruptions in the alignment of the 
sarcomeres were visible in the aged animals (Fig. 2D).  COX activity was 39% lower 
(P<0.05) in senescent animals compared to their younger counterparts (Fig. 5A), similar 
to results previously reported by our laboratory (9).  Fis1 protein levels were 92% higher 
in the SS mitochondrial subfraction of senescent animals, while Drp1 protein was 2.5-
fold higher in the cytosol of aged animals (Fig. 5B).  In contrast to increased expression 
of fission proteins in the senescent animals, we observed a 44% lower expression of the 
fusion protein Mfn2, while Opa1 was unchanged with age.  These data illustrate 
upregulation of the fission proteins with age, while the proteins governing mitochondrial 
fusion are suppressed. 
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Figure 1: Expression of mitochondrial morphology proteins and COX activity from 
skeletal muscle of different oxidative capacities (STR, FTR, FTW).  A) Cytochrome c 
oxidase (COX) enzyme activity of muscles of varying oxidative capacity from 3-month 
old Sprague-Dawley rats (STR, soleus; FTW, red gastrocnemius and quadriceps; and 
FTW, white gastrocnemius and quadriceps; n = 9-10; *P < 0.05 vs FTW, 
†
P < 0.05 vs 
FTR).  B)  Images are representative of 8 separate experiments illustrating the response 
of mitochondrial morphology proteins in varying fiber types, values compared with 
FTW.  Opa1 was quantified by summing all bands resulting from splice variants of the 
protein (*P < 0.05 vs FTW, 
†
P < 0.05 vs STR).  
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Figure 2: Electron micrographs of skeletal muscle under conditions of altered 
mitochondrial biogenesis in Fischer 344 Brown Norway rats in: A) control, B) 
chronic stimulated, C) denervated, and D) aged samples.  Subsarcolemmal and 
intermyofibrillar mitochondrial populations are located below the sarcolemmal 
membrane (black arrows) and between the myofibrils (white arrow heads).  
Morphological alterations in mitochondria are depicted by these representative images 
taken at a magnification of 10,000X.  E) Quantification of the maximal depth of SS 
mitochondria and F) the average area of individual IMF mitochondrial in control, CCA, 
DEN, and aged conditions (*P < 0.05 vs control).   
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Figure 3:  Effect of 7-days of chronic contractile activity (CCA) on mitochondrial 
morphology proteins and COX activity.  A)  COX enzyme activity from chronically 
contracted (CCA) and control (CON) muscle of 6-month old Sprague-Dawley rats (n = 8; 
*P < 0.05 vs control).  B) Fis1, Drp1, Opa1, Mfn2 protein levels in SS mitochondrial or 
cytosolic fractions.  Expression of the morphology proteins was corrected using the 
loading control Porin, and expressed as fold over control.  Representative Western blots 
are shown for each indicated protein, with graphical quantification depicted below (n =7, 
*P < 0.05 vs control).  
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Figure 4:  Expression of mitochondrial morphology protein levels and COX activity 
in control and 7-day denervated (DEN) muscle.  A) COX enzyme activity from 
denervated and control muscle of 6-month old Sprague-Dawley rats (n = 9; *P < 0.05 vs 
control).  B) Representative Western blots of Fis1, Drp1, Opa1, Mfn2 protein expression 
(top), with graphical quantification (bottom) expressed as fold over control. Fis1, Opa1 
and Mfn2 were determined in SS mitochondrial fractions, whereas Drp1 was assessed in 
cytosolic fractions.  Expression of the morphology proteins was corrected using the 
loading control Porin, and expressed as fold over control.  (n = 8, *P < 0.05 vs control).  
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Figure 5:  Fission and fusion morphology protein expression and COX activity in 
young and aged muscle. A) COX enzyme activity from young (5 month) and aged (35 
month) old Fisher 344 Brown Norway rats (n = 5; *P < 0.05 vs aged).   B) Representative 
images of Fis1, Drp1, Opa1, Mfn2 protein content (top), with graphical quantification 
(bottom) expressed as fold over young in SS mitochondrial or cytosolic fractions.  Fis1, 
Opa1 and Mfn2 were determined using SS mitochondrial fractions, whereas Drp1 was 
assessed in cytosolic fractions.  Expression of the morphology proteins was corrected 
using the loading control Porin, and expressed as fold over young.  (n = 6-7, *P < 0.05 vs 
aged). 
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Discussion 
 
The structure of mitochondria within skeletal muscle has been investigated for several 
years.  Ultrastructural studies have quantified differences between fiber types and 
provided detailed characterization of mitochondrial structure in skeletal muscle of 
differing oxidative capacities (25; 27; 33).  These studies have demonstrated that 
mitochondrial structure and volume density are highly variable within muscle (35).  Our 
results demonstrate that the expression of morphology machinery proteins correlates with 
the oxidative capacity of muscle fibers under steady state conditions.   
 The mitochondrial reticular network is known to expand as a result of endurance 
training (27).  This suggests that chronic exercise shifts the expression of fission and 
fusion machinery towards that of enhanced fusion.  In this study, we demonstrate that the 
expected increase in mitochondrial area resulting from CCA was accompanied by a 
concomitant increase in expression of the fusion proteins Mfn2 and Opa1, along with a 
decrease in Drp1 protein levels.  These results provide a molecular basis for the drive 
toward more reticular organelles induced by exercise.  In contrast, denervation-induced 
muscle disuse produced a reduction in mitochondrial content, as evident by reduced 
whole muscle COX activity, decreased thickness of the SS mitochondrial layer, and 
reduced area of individual IMF organelles.  Other studies have found similar reductions 
in organelle size and mitochondrial percentage per fiber area in rat diaphragm muscle 
following denervation (32), suggesting a shift in the balance of mitochondrial dynamics 
towards greater fission and fragmentation.  Our data coincide with morphological 
evidence of mitochondrial fragmentation.  With denervation, we observed that the 
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greatest decrease in protein expression occurred in Mfn2 and Opa1.  This has been 
shown, in part, by Wagatsuma et al (39), who demonstrated a decrease in Mfn2 mRNA 
during hindlimb unloading, and with denervation (40). 
Interestingly, our data on denervation-induced muscle disuse differs from that 
found in aging muscle.  Although mitochondrial content decreased similarly (35 to 40%) 
with denervation and aging, the alterations in fission and fusion proteins differed.  With 
aging, we observed an increase in expression of the fission protein levels of Drp1 and 
Fis1.  In agreement with our study, Koltai et al also found that Fis1 protein expression 
increased with age (28). Thus, the underlying stimuli for changes in gene expression 
differ between denervation and aging, despite the fact that muscle disuse is a common 
feature of both conditions.  Clearly, muscle disuse is only 1 component of the stimuli 
which results in the aging muscle phenotype.  Nonetheless, the end result of this 
divergent pattern of gene expression is similar, with an increased tendency for organelle 
fission, rather than fusion. 
What are the potential mechanisms involved in these changes in gene expression?  
The alterations in mitochondrial biogenesis are driven, in part, by PGC-1α, a major 
regulator of mitochondrial biogenesis (19).  Mice deficient in PGC-1α have reduced 
expression of Mfn2 mRNA (43).  Conversely, up-regulation in PGC-1α, from a single 
bout of cycling exercise stimulated ERRα binding at the -413/-398 motifs on the Mfn2 
promoter, resulting in an increase in Mfn2 mRNA during the recovery phase (8).  Similar 
observations were seen by Ding et al (15), whereby Mfn2 mRNA content increased 
during recovery from acute exercise.  In this study, we chose to avoid the transient nature 
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of mRNA expression and measured the levels of fission and fusion components at the 
protein level under more stable adaptation conditions.  We have previously reported that 
PGC-1α is upregulated by CCA (21), and downregulated by denervation (2) and aging 
(9).  In support of our findings, Garnier et al (18) also found a coordinated increase in 
mitochondrial biogenesis, specifically PGC-1α, and Mfn2 transcriptional levels.  
Although this is certainly consistent with PGC-1α as a regulator of Mfn2 expression 
under these conditions, it is important to note that PGC-1α is only 1 component of the 
process and that additional mechanisms controlling these events have not yet been fully 
elucidated.   
Changes in mitochondrial network formation or organelle fragmentation have 
physiological implications.  The balance between the expression of fission and fusion 
proteins affects mitochondrial sensitivity to apoptotic stimuli, such that fragmented 
mitochondria are more prone to release pro-apoptotic proteins (37).  Mitochondria 
obtained from aging muscle, or from muscle subjected to chronic disuse are similar, with 
higher rates of protein release, greater apoptotic susceptibility (2; 9), and accumulation of 
dysfunctional mtDNA (12).  These mitochondria are likely a product of elevated rates of 
fission, designed to isolate the damaged portion of the mitochondrial network from its 
unaffected parts and to promote the selective clearance of damaged mitochondria through 
mitophagy (36). 
In contrast, extended mitochondrial reticula may have advantages over smaller 
isolated mitochondria in that they can serve as an effective system for electrically-
coupled power transmission throughout the cell (7).  Muscle fibers are quite large in size, 
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and significant gradients exist for substrates within muscle (7).  In such an instance, the 
expanded mitochondrial network may facilitate rapid delivery of O2 and lipid-soluble 
substrates from regions of high to low availability.  Consequently, expansion of the 
mitochondrial network provides physiological advantages to the cell under conditions of 
high metabolic demand, such as exercise. 
In summary, our data show that chronic muscle use induces a shift in the balance 
of the regulatory proteins involved in fission and fusion toward upregulation of the fusion 
process.  In contrast, chronic muscle disuse promotes expression of proteins which are 
involved in organelle fragmentation, an outcome similar to that observed in aging muscle, 
albeit through a divergent pathway.  These changes in fission and fusion machinery 
components are an important part of the adaptive responses of skeletal muscle 
mitochondria to changes in muscle use, disuse, and aging, with physiological 
implications for energy production and organelle turnover. 
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Rationale for Manuscript #2 
  Mitochondria are distributed in the cell to match the energy demands, and it is their 
interaction with the cytoskeleton that controls their movement and displacement. Our 
purpose was to determine which cytoskeletal components are primary responsible for 
mitochondrial movement in muscle cells. 
  In neurons, microtubules are the primary tracks governing mitochondrial 
movements.  Based on this knowledge, we hypothesized that microtubules, and their 
associated motor proteins are the main cytoskeletal filament proteins involved in 
mitochondrial dynamics within skeletal muscle.   
SI and DAH conceived and designed the experiments, interpreted the data and 
wrote the manuscript.  SI collected and analyzed all the data.  Both authors approved the 
final version of the manuscript. 
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Abstract 
 
Mitochondria are distributed in the cell to match the energy demands, and it is their 
interaction with the cytoskeleton that controls their movement and displacement. Our 
purpose was to determine which cytoskeletal components are primarily responsible for 
mitochondrial movement in muscle cells.  Live-cell imaging was used to visualize 
mitochondrial dynamics in myoblasts.  Destabilization of microtubules (MT) reduced the 
total path length and average speed traveled by mitochondria by 64–74%, whereas actin 
disruption only reduced these variables by 37-40%.  Downregulation of the microtubule 
motor proteins, Kif5B and dynein, by siRNA resulted in similar decreases in the average 
speed of mitochondrial movements, by 30-40%.  We observed a reduction in 
mitochondrial average speed of movement (by 22-48%) under high calcium conditions.  
This attenuation in mitochondrial movement in the presence of calcium was negated in 
cells pre-treated with siRNA targeted to the microtubule motor protein adaptor, Milton, 
suggesting that Milton is involved in mediating mitochondrial arrest in the presence of 
calcium in muscle cells.  By understanding mitochondrial movements we can elucidate 
the underlying basis for organelle interactions, leading to the formation of the 
mitochondrial reticulum, particularly during conditions of elevated calcium, such as 
exercise. 
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Introduction 
 
Mitochondria are vital organelles, critical for energy supply and cell survival.  Such 
functional versatility is paralleled by the structural complexity of the organelle.  
Mitochondria can compensate for alterations in energy requirements by adjusting their 
size and distribution within skeletal muscle (5).  It is their interaction with the 
cytoskeleton that is used to control their position, movement and anchorage within cells 
(23).  The three cytoskeletal elements, actin, microtubules and intermediate filaments act 
to vary the degree of scaffolding along which mitochondria are capable of moving.   
The distribution of mitochondria to specific sites within the cell has consistently 
been linked to microtubules and actin.  In neurons and cardiac myocytes, microtubules 
are the primary tracks governing mitochondrial movements (15; 26), while in S. 
cerevisiae the positioning of mitochondria is reliant on actin-based transportation (20). 
Intracellular transport of cargo, such as mitochondria, to specific locations within the 
cytoplasm involves molecular motors that bind directly to the cargo and the cytoskeletal 
track.  Dynein and kinesins motor proteins use microtubules to transport cargo 
throughout the cell.  In neurons, movement along microtubules occurs either towards the 
cell body using cytoplasmic dynein, or away, using kinesins.  There are 14 kinesin 
superfamilies encoded by the human and mouse genomes, consisting of more than 45 
members (10).  In neurons, Kinesin-1 and Kinesin-3 have been identified to regulate 
mitochondrial movements (16; 19).  Kinesin-1, also known as conventional kinesin, 
consists of three distinct members, Kif5A, Kif5B and Kif5C.  Kif5A and Kif5C are 
neuron-specific, whereas Kif5B is ubiquitously expressed (1; 2).  Inhibition of Kinesin-1 
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in Drosophila halts mitochondrial movement in motor axons (19), and in non-neuronal 
cells, whereby deletion of Kif5B alters mitochondrial positioning (23; 25).  The 
movement of motor proteins along microtubules takes advantage of the dynamic 
instability of the tubulin polymer.  Growth of microtubules allows for the continued 
expansion of the cytoskeleton, which motor proteins use as tracks. Conversely, the ability 
of microtubules to shrink is thought to be important for morphological changes in the 
cell, and in the reorientation of microtubules during the locomotion of organelles (13).   
In muscle, calcium (Ca
2+
) is a key regulator of contractile activity, but it is also an 
important signaling ion.  Ca
2+
 has a role in the regulation of mitochondrial respiration, 
and it is involved in the opening of the mitochondrial permeability transition pore 
(mtPTP) (4).  This dissipates the electrochemical proton gradient, thereby halting ATP 
production by oxidative phosphorylation.  Calcium influx has also been found to inhibit 
mitochondrial movement in neurons and in cardiac myocytes (12; 24; 26).  The ability of 
mitochondria to respond to intracellular signals such as Ca
2+
, is mediated by motor 
protein/adaptor complexes.  The core of this complex is composed of the Kinesin-1 motor 
along with two mitochondrial-specific adaptors, mitochondrial Rho GTPase (Miro) and 
Milton (24).  Milton binds directly to Kinesin-1 (21), whereas Miro serves as an anchor 
linking Milton and Kinesin-1 to mitochondria (8).  Elevated calcium binds to the EF-
hands of Miro and induces a conformational change in the protein, resulting in the 
dissociation of the complex from microtubules and arresting mitochondrial movements 
(12; 24).    
 87 
Traditionally, mitochondria have been thought to be static in nature, but are now 
known to be quite dynamic within cells.  However, what is unknown is how the 
distribution of mitochondria are controlled and regulated.  By understanding 
mitochondrial movements we can elucidate the underlying basis for organelle 
interactions, leading to the formation of the mitochondrial reticulum, and the distribution 
of energy in muscle cells. 
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Experimental Procedures 
Cell Culture and Transfections:  C2C12 murine skeletal muscle cells were grown in 
DMEM supplemented with 10% fetal bovine serum and 1% Penicillin/Streptomycin 
(Growth Media, GM).  Cells were cultured in custom made glass bottom culture plates 
and maintained at 37
o
 in 5% CO2.  Upon reaching a confluence of approximately 60%, 
mito-DsRED2 was transfected into myoblasts using Lipofectamine 2000 (Life 
Technologies) to visualize mitochondria.   Mitochondrial movement was observed in 
C2C12 cells using an expression vector that encodes a fusion of red fluorescence protein 
and the mitochondrial targeting sequence from cytochrome c oxidase subunit VIII (mito-
dsRED2).   
Treatments:  Forty-eight hours following transfection with mito-DsRed2, myoblasts were 
treated with microtubule and/or actin disrupting drugs, or a vehicle control (DMSO; 
Sigma-Aldrich). Microtubules were depolymerized using nocodazole (20μM; Toronto 
Research Chemicals) and colchicine (20μM; Sigma-Aldrich), while Taxol (2μM; Sigma-
Aldrich) was used for stabilization.  Actin was disrupted using cytochalasin D (2μM; 
Enzo Life Sciences). Pre-incubation with these agents was 1 hr prior to imaging. 
In order to study the regulation of mitochondrial dynamics by calcium, C2C12 
cells were treated with either ionomycin (1μM, Sigma-Aldrich), a Ca2+ ionophore, or 
thapsigargin (1μM, Enzo Life Science), an inhibitor of the sarcoplasmic reticulum Ca2+-
ATPase.  Ca
2+ 
levels were suppressed using the chelators EGTA (5mM, Sigma-Aldrich) 
and BAPTA-AM (2μM, Calbiochem).  
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Mitochondrial Movement Analysis:  Mitochondria were visualized using an inverted 
Nikon Eclipse TE2000-U fluorescent microscope equipped with 100x/1.5 oil objective 
lens, with a custom designed chamber designed to maintain a constant temperature of 
37
o
C with 5% CO2.  Mitochondrial dynamics were captured at 2 sec intervals for a total 
time of 5 mins using real-time imaging. Analyses were performed using the NIS Element 
AR 3.1 software, and was limited to regions of interest in the periphery of the cells, 
where individual mitochondria were readily resolved and could be used for analysis, 
while avoiding the confounding influence of high density mitochondrial networks.   
Immunocytochemistry of Actin and Microtubules:  For immunocytochemistry, the 
transfected cells were washed 3x with PBS at room temperature.  The cells were then 
fixed with 3.7% formaldehyde for 7 min and washed with 3x with PBS.  Cells were 
permeabilized with 0.1% Triton X-100 at 4 °C for 15 min and washed 3X with PBS. 
Subsequently, cells were stained with a FITC conjugated α-tubulin primary antibody 
(Abcam), or Acti-stain 488 phalloidin (Cytoskeleton Inc) for 2 hrs or 30 mins, 
respectively.  The cells were then washed 3X with PBS and incubated with DAPI 
(Sigma-Aldrich) for 5 mins to stain the DNA.  After washing twice with PBS, the media 
was replaced with GM without phenol red. 
RNA Interference: Silencer Select predesigned small interfering RNA (siRNA) for 
Kif5B (5’-GACAUGUCGCAGUUACAATT-3’), dynein (Dynch1; 5’-
GAAAGAUCCGCAACACGAATT-3’), Milton (TRAK1; 5’-
GCAACGUGGUCCUCGAUAATT-3’) and scrambled controls (scRNA) were used in 
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the knockdown experiments (Ambion).  To produce knockdowns, the media was 
switched to pre-transfection media (DMEM and 10% FBS).  The following day, the 
media was changed to DMEM and myoblasts were incubated with mito-DsRED2, and 
either 50 nM of siRNA specific for Kif5B or dynein, or 100 nM of siRNA for TRAK1, 
along with 10 μl of Lipofectamine 2000 for 6 hrs.  Concomitantly, scrambled non-
targeting siRNA underwent the same conditions.  Forty-eight hours post-transfection, 
cells were used for image analysis or were collected for protein extracts. 
Immunoblotting: Protein extracts from myoblasts were separated on 6–15% SDS-PAGE 
and subsequently transferred onto nitrocellulose membranes. Membranes were then 
blocked (1 hr or 1.5 hr) with a 5% skim milk in 1x TBS-Tween20 solution (Tris-buffered 
saline–Tween-20: 25 mM Tris–HCl, pH 7.5, 1 mM NaCl and 0.1% Tween-20) at room 
temperature, followed by incubation in blocking solution with antibodies directed 
towards Kif5B (1:500; Santa Cruz), Dynein heavy chain (1:1000; Santa Cruz), PGC-1α 
(1:500; Millipore), COX IV (1:250; Abcam), COX I (1:500; MitoSciences), or α-tubulin 
(1:2000; Calbiochem) overnight at 4°C. Subsequently, membranes were washed 3x 5 min 
with TBS-Tween20, followed by incubation at room temperature (1 hr) with the 
appropriate secondary antibody conjugated to horseradish peroxidase, and washed again 
3x for 5 min each with TBS-Tween20.  Membranes were developed using Western Blot 
Luminol Reagent (Santa Cruz).  Films were subsequently scanned and quantified via 
densitometric analysis for the intensity of signals with SigmaScanPro software (version 5, 
Jandel Scientific). 
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Real-time PCR:  Total RNA was extracted from C2C12 cells 48 hrs after transfection, as 
previously described (18).  The concentration and purity of the RNA was assessed using 
absorbance readings at 260 and 280 nm (Ultrospec 2100 Pro).  In accordance with the 
manufacturer’s recommendations, SuperScript® III reverse transcriptase (Invitrogen) was 
used to reverse transcribe the RNA into cDNA.  Using sequences from GenBank, primers 
were designed with Primer 3 v. 0.4.0 software (Massachusetts Institute of Technology, 
Cambridge, MA) for Milton as the gene of interest, with glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and β2-microglobulin (β2M) serving as the endogenous 
controls.  The primers used were as follows: Milton forward: 5'-
GGGAACGAGGACCACAATAA-3', Milton reverse: 5'-
CCTCCGCTCAGACAGGTAGT-3', GAPDH forward: 5'-
AACACTGAGCATCTCCCTCA-3', GAPDH reverse: 5'-
GTGGGTGCAGCGAACTTTAT-3', β2M forward: 5’- GGTCTTTCTGGTGCTTGTCT-
3’, β2M reverse: 5’- TATGTTCGGCTTCCCATTCT-3’.  Quantification of the gene of 
interest was corrected using the endogenous controls and analyzed as previously 
described (18). 
Oxygen Consumption:  Oxygen consumption was determined based on fluorescence 
quenching by oxygen using OxoPlates (Innovative Instruments).  Cells were added to 
each well at a density of 8000 cells/well. The following day, cells were pre-incubated (1 
hr) with the microtubules and/or actin disrupting agents.  Optical oxygen sensors at the 
bottom of microplates contained an indicator and a reference dye.   Wells containing air-
saturated (100%) and oxygen-free (0%) solutions were used for calibration.  Fluorescence 
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was assessed for 3.5 hrs in 3 min intervals in dual kinetic mode (Synergy HT microplate 
reader), using filter 1 (530/645 nm) and filter 2 (530/590) settings in order to detect 
fluorescence of the indicator and reference dyes, respectively.  From these values, ratios 
were calculated and compared to the standard calibrations, thus allowing quantification of 
oxygen consumption. 
Calcium Imaging: Cells were washed with GM without phenol red and incubated in the 
dark for 40 mins in a solution containing the calcium-sensitive dye fura-2-acetoxymethyl 
ester (Fura-2 AM, 5µM) and 0.02% pluronic F-127.  Fura-2 AM-loaded cells were 
washed twice and the media was replaced with GM without phenol red for an additional 
20 mins to allow the de-esterification of fura-2 AM to occur.  Prior to imaging, the media 
was replaced.  Ratiometric imaging at absorption wavelengths of 340 and 380nm 
(emission 510nm) was taken at 30 sec intervals.  Changes in the ratio of fluorescence 
intensity obtained at 340 nm (fura-2-Ca
2+
 bound) to that of 380 nm (Ca
2+
 free fura-2) 
were used to assess Ca
2+
 levels following the addition of either ionomycin or thapsigargin 
to the media, to stimulate the release of calcium, and following the chelation of calcium 
by EGTA or BAPTA-AM. 
Statistical Analyses:  Data were analyzed with GraphPad 4.0 software and expressed as 
means ± SE. T-tests and 1-way ANOVAs were performed where appropriate, and 
differences were considered statistically significant if P < 0.05. 
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Results 
Microtubules are the primary filaments used by mitochondria during trafficking.  To 
elucidate which cytoskeletal elements are primarily responsible for mitochondrial 
motility within myoblasts, we disturbed microtubules and actin, and observed their 
effects on organelle movement.  We examined the co-localization of actin (Fig 1A) and 
mitochondria (Fig 1B) in control cells (Fig 1C), and compared them to myoblasts 
exposed to the actin disrupting agent cytochalasin D (Fig 1D).  Exposure to cytochalasin 
D resulted in the drastic rearrangement of actin filaments, such that they appeared 
disjoined and no longer extended throughout the length of the cell.  Actin disruptions 
reduced the total path length and average speed of mitochondria by 37 and 40%, 
respectively (Fig 1I and 1J).   
Next, we then examined the effects of microtubule disruptions on mitochondrial 
dynamics. Cells stained with FITC-conjugated α-tubulin antibodies and treated with 
colchicine or taxol, displayed alterations in the structure of microtubules compared to 
untreated myoblasts (Fig 1F–H).  The destabilize agent, colchicine, resulted in enhanced 
depolymerization of microtubules (Fig 1G).  Conversely, the stabilizer, taxol is known to 
block microtubule disassembly.  As depicted in Figure 1H, taxol preventing normal 
polymerization of the filaments. 
  In response to depolymerization of microtubules using nocodazole and colchicine, 
the total path length of mitochondria was reduced by 64–72% (Fig 1I), similar reductions 
were observed in the average speed traveled by the organelles (68–74%, Fig 1J).  In 
addition, the stabilization of microtubules by taxol also significantly altered 
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mitochondrial motility, albeit to a lesser degree (Fig 1I and 1J).  To deduce the effects 
that microtubule and actin disruption would have in combination, we co-incubated 
myoblasts with nocodazole and cytochalasin D.  Changes in mitochondrial motility were 
similar to the results observed with nocodazole treatment alone.  We then ascertained 
whether disruptions in the cytoskeleton and mitochondrial movement had any effect on 
oxygen utilization. No significant effects on oxygen consumption were observed (Fig 
1K). 
 
Treatment with microtubule disrupting drugs arrested mitochondria to a greater extent 
than actin depolymerization. Given the effects that cytoskeletal disruption had on 
mitochondrial speed, it was of interest to examine whether this reduction was due to 
slower movements, or to an overall greater percentage of time that mitochondria 
remained stationary.  By transfecting mito-dsRED2 to visualize mitochondria (Fig 2A), 
we determined the percentage of time that mitochondria spent in motion.  To analyze the 
movement characteristics of individual mitochondria, kymographs were generated from 
the live-cell imaging videos to document the dynamic properties of the organelles.  We 
determined that mitochondria remained in constant motion, and frequently changed their 
direction (Fig 2), as reflected by horizontal deviations in the kymograph tracings.  The 
addition of microtubule disrupting agents reduced the motility of mitochondria, as 
depicted by decreased horizontal deviations in the kymograph tracings over the 5 min 
recording period with the addition of colchicine, nocodazole, or taxol.  Interestingly, the 
kymograph data generated from treatment with cytochalasin D was comparable to control 
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conditions.  Quantification of organelle motility revealed that alterations in microtubules 
increased the percentage of time that mitochondria were stopped by 1.6 – 2.7-fold (Fig 
2C).  However, changes to the structure of actin filaments using by cytochalasin D 
treatment had no significant effect on the amount of time mitochondria were in motion in 
these myoblasts. 
 
Knockdown of microtubule motor proteins attenuates mitochondrial dynamics. For 
mitochondria to bind to cytoskeletal elements, motor proteins are required.  The 
transfection of siRNA probes against Kif5B and dynein in C2C12 myoblasts resulted in 
significant reductions in their protein levels by 59 and 40%, respectively (Fig 3A and 
3B).  The reduction in Kif5B was specific, and did not alter levels of mitochondrial 
biogenesis markers (Fig 3A) or mitochondrial morphology proteins Mfn2, Opa1, Fis1, or 
Drp1 (unpublished observations).  Reductions in both Kif5B and dynein resulted in 
similar significant decreases in the average speed of mitochondrial movements, by 30–
40%, as well as in the total path length travelled by the organelles (decreased by 28–37%, 
Fig 3C and 3D). 
  
Cytosolic calcium regulates mitochondrial movement in myoblasts. Calcium is an 
important signaling molecule in skeletal muscle, and as such we were interesting in 
examining its effects on mitochondrial motility.  The Ca
2+
 ionophore, ionomycin, 
triggered an increase in Ca
2+
 levels that was suppressed by the addition of EGTA, as 
assessed by Fura2-AM ratiometric analysis (Fig 4A and 4B).  The rising phase of the 
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cytosolic Ca
2+
 spike was accompanied by decreases in organelle motility in myoblasts 
(Fig 4B and 4C).  The total path length and average speed traveled by mitochondria were 
attenuated by 42 and 48%, respectively.  The addition of EGTA permitted the recovery of 
mitochondrial movement, which coincided with reductions in the amount of cytosolic 
Ca
2+
, (Fig 4A-C).  Similar effects were observed with the incubation of thapsigargin, a 
SERCA inhibiting agent.  The addition of thapsigargin significantly reduced the total 
path length and average speed of mitochondria by 19 and 22%, respectively (Fig 4E and 
F).  Mitochondrial motility and Ca
2+
 levels returned to resting levels with the addition of 
the Ca
2+
 chelator BAPTA-AM (unpublished observations). 
 The mechanisms by which Ca
2+
 exerts its effects are still under investigation.  
Milton is thought to be involved, since in neurons, Milton links mitochondria to Kif5B 
motor proteins, allowing mitochondria to move along microtubules in a Ca
2+
-dependent 
manner (12; 24).  Thus, we reduced the level of Milton in myoblasts and observed its 
influence under conditions of elevated Ca
2+
 in the presence of thapsigargin (Fig 4G).  The 
decrease in mitochondrial speed of movement observed with thapsigargin treatment alone 
was negated in cells pre-treated with Milton siRNA, suggesting that Milton is involved in 
mediating mitochondrial arrest in the presence of Ca
2+
.   
 
 
 
 
 
 
 
 
 
 
 97 
 
Figure 1
K
O
x
y
g
e
n
 C
o
n
su
m
p
ti
o
n
(%
 o
f
c
o
n
tr
o
l)
C
O
N
N
O
C
C
O
L
C
T
A
X
O
L
C
Y
T
.D
N
O
C
+
C
Y
T
 D
0
25
50
75
100
125
CYT D TAXOL
COLC
Phalloidin-Actin
Mito-dsRED2
J
0
1
2
3
4
5
6
*
*
*
*
*Av
e
ra
g
e
 S
p
e
e
d
(μ
m
/s
) 
[x
1
0
0
]
C
O
N
N
O
C
C
O
L
C
T
A
X
O
L
C
Y
T
.D
N
O
C
+
C
Y
T
 D
I
0
5
10
15
20
25
*
*
**
*
T
o
ta
l 
P
a
th
 L
e
n
g
th
 (
μ
m
)
C
O
N
N
O
C
C
O
L
C
T
A
X
O
L
C
Y
T
.D
N
O
C
+
C
Y
T
 D
A
DAPI-Nucleus
CON
CON
C
B
G
H
F
D
E
 98 
Figure 1: Microtubules are the primary filaments used by mitochondria during 
trafficking.  A: Myoblasts stained with phalloidin (green) alone, B: transfected with 
Mito-dsRED2 (red), or E: stained with DAPI for nuclei (blue).  C: Merged images are 
overlays of phalloidin, Mito-dsRED2 and DAPI. Non-treated cells exhibited normal 
morphology of actin filaments.  D: After 1 hr of treatment with cytochalasin D (CYT D), 
myoblasts presented cells with actin disruptions.  F:  Additionally, untreated myoblasts 
display normal microtubule (green, GFP-tubulin), mitochondria (red, Mito-dsRED2) and 
nuclei (blue, DAPI) organization. G: Myoblasts pre-treated with the microtubule 
disrupting agents Colchicine (COLC) and H: TAXOL for 1 hr exhibited alterations in the 
microtubule structure. COLC and Taxol were successful at disrupting microtubules, as 
indicated by the images above.  I: Quantification of the total path length and J: the 
average speed traveled by mitochondria over the 5 min capturing time.  Movement of 
mitochondria was determine from an average of n=36–72 mitochondria from 9 separate 
cells.  K: Oxygen consumption was assessed in myoblasts with microtubule and/or actin 
disruptions using the microtubule disruptors Nocodazole (NOC), COLC, Taxol, and/or 
the actin disrupting agent CYT D, along with a control treatment (CON, DMSO).  Values 
are expressed as averages ± SEM, N=6. *Significantly different from CON, P < 0.05. 
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Figure 2: Treatment with microtubule disrupting drugs arrested mitochondria to a 
greater extent than actin depolymerization.  A: Mitochondrial movement in a 
representative myoblast transfected with mito-DsRed2. B: The first frame in a live-cell 
imaging series is displayed above with representative kymographs generated from the 
movies from control (CON, DMSO) Nocodazole (NOC), Colchicine (COLC), Taxol, 
Cytochalasin D (CYT D), or NOC + CTY D treatments. Time (0-5 min) progresses from 
the top to bottom in the kymograph.  Whereas, the x-axis represents mitochondrial 
position.  Vertical white lines correspond to stationary mitochondria, and horizontal 
deviations (vibrations from the vertical) depict moving mitochondria.  C: The percentage 
of time that mitochondria spent in motion as a result of microtubule and actin disruptions 
was determined by monitoring the position of the organelle throughout the capturing 
time.  Mitochondria were considered in motion if movement was greater than 0.01μm in 
the 2 sec of capturing time.  Movement of mitochondria was determined and averaged 
from n=36-72 mitochondria from 9 separate cells.  Error bars represent mean ± SEM, *P 
< 0.05 vs. CON. 
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Figure 3:  Knockdown of microtubule motor proteins attenuates mitochondrial 
dynamics.  A: Representative Western blots of markers of mitochondrial content in 
myoblasts treated with either scrambled control (scRNA CON) or siRNA for Kif5B 
(above). Quantification of protein expression of Kif5B siRNA and scRNA control 
(below).  B: Representative Western blots of dynein treated with an antisense probe and 
its respective scRNA control (above), along with graphical quantification (below).  α-
tubulin was unchanged between the conditions and was used as a loading control.  
Experiments were repeated for 5 separate trials.  C: The total path length and D: the 
average speed traveled by mitochondria was assessed in scRNA CON and siRNA 
treatment for Kif5B and dynein.  Movement of mitochondria was averaged from n=20–
40 mitochondria from 5 separate cells, *P < 0.05 vs. CON scRNA.   
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Figure 4:  Cytosolic calcium regulates mitochondrial movement in myoblasts. A: 
Intracellular calcium levels were assessed in Fura2-AM loaded C2C12 cells.  Fura2 
fluorescence was measured using excitation of Ca
2+
-bound (340nm, red) and the Ca
2+
-
free form (380nm, green).  Thus, elevations evoked by the addition of Ionomycin (ION) 
and Thapsigargin (TG) appear as increases in the red component.  Elevated calcium 
concentrations were achieved through the addition of ionomycin and reduced by EGTA.  
B, C: Increased calcium attenuated mitochondrial movement, and organelle transport was 
recovered by the addition of EGTA.  Endogenous calcium levels were elevated with 
Thapsigargin treatment and suppressed with BAPTA-AM.  D, E: High calcium 
concentrations inhibited the total path length and the average velocity traveled by the 
organelles.  (n=6–8, *P < 0.05 vs CON).  F: Milton mRNA levels were assessed in 
myoblasts treated with 100 nM of scRNA or siRNA specific for Milton (left).  The 
average speed traveled by mitochondria was determined in scRNA and siRNA 
transfected C2C12 cells, treated with Thapsigargin and BAPTA-AM (right). 
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Discussion 
In order to efficiently supply the cell with energy, mitochondria must be transported to 
areas of high energy demands.  In neurons, mitochondria are delivered to areas where 
they required, and retained at sites where energy demand is high, such as growth cones, 
nodes of Ranvier and synapses (3; 7; 14).  Within neurons, areas of high activity possess 
greater densities of mitochondria (11; 17).  The movement of mitochondria to specific 
sites within the cell is dependent on a cytoskeleton-based transportation system.  
Moreover, environmental and physiological changes are thought to influence the 
positioning of organelles within the cells.  Thus, our purpose was to determine which 
cytoskeletal components were primarily responsible for mitochondrial movement within 
myoblasts, and to investigate the effects of calcium on mitochondrial motility.  To do so, 
we utilized live-cell imaging techniques to monitor the dynamics of these organelles.  
 To address the influence of the cytoskeleton on mitochondrial motility we 
assessed 1) the total path length, 2) average speed, and 3) percentage of time that 
organelles remained stationary.  Our results indicate that microtubule disruption resulted 
in greater impediments in mitochondrial motility as compared to conditions in which 
actin polymerization was disturbed in myoblasts.  Administration of microtubule 
depolymerizing or stabilizing agents resulted in similar effects on mitochondrial motility, 
yet they varied in the degree of their effects.  These variations are likely due to 
differences in the organization of the microtubules.  Microtubules are normally 
dynamically unstable, undergoing constant polymerization and depolymerization.  The 
presence of taxol enhances the stability of microtubules, rendering them more susceptible 
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to undergoing post-translational modifications, such as acetylation, detyrosination, and 
polyglutamylation (9).  Recently it has been found that Kinesin-1 binds preferentially to 
detyrosinated microtubules, and these kinesins move at slower velocities (6).  These post-
translational modifications may explain the disparity between the effects of taxol and 
nocodazole or colchicine treatments.   
Since kinesin and dynein motors drive the movement of mitochondria along 
microtubules, we speculated that the downregulation of these components would alter 
organelle transport.  By reducing the levels of Kif5B, a member of the Kinesin-1 family, 
we observed decreased mitochondrial motility.  It has previously been reported that the 
deletion of similar kinesin-1 family members in fungus and mouse neurons, led to altered 
mitochondrial distribution (23; 25).  Analyses in the Drosophila nervous system support 
the concept that the primary motors for mitochondrial movement are Kinesin-1, in 
coordination with dynein, which moves mitochondria in the opposite direction (12). 
Calcium influx has been found to inhibit mitochondrial movement in neurons and 
cardiac myocytes using motor protein/adapter complexes (17; 19).  However, the 
influences of Ca
2+
 within skeletal muscle, as well as the mechanism by which Ca
2+
 exerts 
its effects are still under investigation.  Our results indicate that elevations in Ca
2+
 exert a 
negative effect on mitochondrial movement, and cause an inhibition of motility.  Linker 
proteins coordinate the movement of mitochondria with environmental signals, and are 
necessary for proper localization of the organelle.  In neurons, HEK293 and COS-7 cells, 
Milton acts as a mitochondrial-specific linker that redistributes the organelle to 
appropriate regions within the cell, in response to increases in Ca
2+ 
(14; 15; 17).  
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Mutations in the protein result in mitochondrial trafficking defects, while other organelles 
retain their normal distribution (15).  In this context, it is interesting that we observed 
Milton to also have a vital role in mitochondrial movement when Ca
2+
 levels were 
elevated in myoblast cells.  Inhibition of Milton disrupted Ca
2+
-induced mitochondrial 
transport.  Thus, Milton may mediate associations between Kinesin-1 and mitochondria 
in muscle cells. 
We next wanted to examine the effect that chronic changes in motility might have 
on mitochondrial content.  Argyropoulos et al previously found that inhibition of the 
motor protein, Kif5B, reduced cytochrome b mRNA (2).  Therefore, we speculated that 
reductions in Kif5B would alter the expression of proteins involved in mitochondrial 
biogenesis.  We observed no change when we examined the prominent regulator of 
mitochondrial biogenesis, PGC-1α, as well as the mitochondrially- and nuclear-encoded 
proteins COXI and COXIV, respectively.  Therefore, our data are not consistent with a 
role for changes in motor protein expression on mitochondrial biogenesis. 
In summary, mitochondria primarily move along microtubules tracks.  In 
myoblasts, mitochondria can pause, change their direction, and their velocity of 
movement.  Displacement within myoblasts is regulated by physiological signals, such as 
Ca
2+
, which inhibits mitochondrial movements in a Milton-dependent manner.  By 
understanding mitochondrial movements and the signaling events that regulate their 
dynamics, we can elucidate the underlying basis for organelle interactions, leading to the 
formation of the mitochondrial reticulum and the distribution of energy in muscle cells.  
Mitochondrial transport is important not only during organelle biogenesis, but also for 
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recycling and degradation of cellular components. Whether these events happen in fully 
mature skeletal muscle, in which physical constraints are imposed by the presence of 
myofibril proteins, remains to be established.  It is known that mitochondria form a dense 
network when they form myotubes, but their motility has never been analyzed.  Future 
studies examining this possibility, and even extrapolating to contracting muscle fibres 
will be important for understanding how mitochondrial biogenesis and the reticulum form 
during conditions of increased oxidative capacity.   
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Rationale for Manuscript #3 
Mitochondria are dynamic organelles, continuously undergoing cycles of fission 
and fusion, resulting in alterations in their morphology and function, however the 
mechanisms governing these changes have yet to be fully elucidated.  Hence, we sought 
to determine the effects of oxidative stress on mitochondrial dynamics. 
The connection between oxidative stress and mitochondrial morphology has 
previously been shown in endothelial cells and neurons, and recently in C2C12 
myoblasts.  Whereby, exposure to high levels of ROS induces mitochondrial 
fragmentation.  Based on these finding, we hypothesized that an increase in oxidative 
stress would fragment the mitochondrial network and reduce mitochondrial motility.   
SI and DAH conceived and designed the experiments, interpreted the data and 
wrote the manuscript.  SI collected and analyzed all the data.  Both authors approved the 
final version of the manuscript. 
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Abstract 
Mitochondria are dynamic organelles, continuously undergoing cycles of fission and 
fusion, resulting in alterations in their morphology and function, however the 
mechanisms governing these changes have yet to be fully elucidated.  Hence, we sought 
to determine the effects of oxidative stress on mitochondrial dynamics in mouse 
myoblasts.   We demonstrated that acute exposure to oxidative stress with H2O2 resulted 
in a 41% increase in fragmentation of the mitochondrial reticulum within 3 hours of 
exposure, an effect that was preceded by a reduction in membrane potential.  Using live-
cell imaging, we monitored mitochondrial motility and found that oxidative stress 
resulted in a 30% reduction in the total path length and average velocity travelled by 
mitochondria within myoblasts.  This attenuation in mitochondrial movement was 
abolished by the addition of N-acetylcysteine, a reactive oxygen species scavenger.  To 
investigate whether H2O2-induced fragmentation was mediated by the action of Drp1, we 
incubated cells with mDivi1, an inhibitor of Drp1 translocation to mitochondria.  mDivi1 
attenuated oxidative stress-induced mitochondrial fragmentation by 27%.  Thus, the 
observed oxidative stress-induced mitochondrial fragmentation was mediated, in part, by 
Drp1.  Moreover, we demonstrated that exposure to oxidative stress activated the ER-
unfolded protein response prior to the initiation of mitophagy and the mitochondrial-
unfolded protein response pathways.  These findings indicate that oxidative stress is a 
vital signaling mechanism in the regulation of mitochondrial morphology and motility.  
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Introduction 
 
Mitochondria are essential organelles for the life and death of eukaryotic cells.   They 
play key roles in aerobic energy production, apoptosis, mitophagy and cellular signaling.  
These versatile organelles were once thought to be static and rigid structures.  More 
recently, mitochondria have been appreciated for their dynamic nature.  They can change 
their distribution by moving along cytoskeletal tracks, or change their overall 
morphology.  The maintenance and appropriate networking of mitochondria within the 
cell is mediated by fusion and opposing fission processes.  Fusion involves the mixing of 
mitochondrial material, whereas fission divides the organelle into smaller components.  
Disruptions in either of these opposing events can lead to developmental defects and 
disease (29), suggesting that the proper maintenance  of  mitochondrial morphology is 
critical for normal cell function.   
Mitochondrial fission is orchestrated, in part, by Drp1 (4; 25), a protein that is a 
GTPase of the dynamin family.  All dynamin members are structurally similar, but 
functionally diverse GTP-binding proteins.  Drp1 assists in mitochondrial fission by 
polymerizing into a ring-like structure around the organelle.  The cross-bridging of the 
GTPase domains of adjacent Drp1 proteins results in GTP hydrolysis, constriction, and 
the ultimate severing of mitochondria (26).  It is the phosphorylation status of Drp1 that 
determines its localization and consequently its effect on mitochondrial structure.  Ser
637
 
phosphorylation results in inhibition Drp1 GTPase activity, preventing the protein from 
translocating from the cytosol to the sites of mitochondrial division, thereby inhibiting 
organelle fission (9; 11).   
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Mitochondria are the primary source of reactive oxygen species (ROS) 
generation.  Within these organelles, low levels of ROS are constantly produced during 
normal respiration when the O2 consumed undergoes a one-electron reduction.  In 
skeletal muscle subject to conditions of chronic muscle disuse (1) and aging (8), an 
increased production of ROS from mitochondria occurs, and this coincides with an 
increased incidence of mitochondrial fragmentation (19).  More direct connections 
between oxidative stress and mitochondrial morphology have previously been shown in 
endothelial cells and neurons, and recently in C2C12 cells, whereby exposure to high 
levels of hydrogen peroxide, a major contributor to oxidative stress, induces 
mitochondrial fragmentation (3; 5; 21).   
To promote proper functioning of mitochondria in the face of ROS-induced 
damage, the cell has quality control mechanisms in place.  The endoplasmic reticulum 
(ER) and mitochondria (mt) are exposed to newly synthesized protein and are responsible 
for their proper folding and assembly.  Homeostasis is achieved by balancing the nascent 
protein load with the folding capacity of the organelle.  When the ability to do so is 
compromised, ER and mitochondrial stress ensues.  The adaptive responses to this 
imbalance, termed the ER-unfolded protein response (UPR) and mt-UPR, coincide with 
the upregulation of molecular chaperones allowing for the increased folding capacity of 
the cell.  If the cellular stress is too extensive and cannot be alleviated, the UPR activates 
cell destructive responses including  apoptosis and the mitophagy pathway (24).   
Mitochondria are dynamic organelles, continuously moving and undergoing 
cycles of fission and fusion, resulting in alterations in their displacement, morphology, 
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and function, however the mechanisms governing these changes have yet to be fully 
elucidated.  Hence, we sought to determine the effects of ROS on mitochondrial 
dynamics in myoblasts and to establish the interplay between mitochondrial morphology 
and stress responses during conditions of oxidative stress.   
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Experimental Procedures 
Cell Culture and Treatments:  C2C12 murine skeletal muscle cells were plated into 6-
well dishes and allowed to proliferate in DMEM supplemented with 10% fetal bovine 
serum and 1% Penicillin/Streptomycin (Growth Media, GM).  Upon reaching a 
confluence of approximately 60%, the mito-DsRED2 plasmid was transfected into 
myoblasts using Lipofectamine 2000 (Life Technologies), thus allowing for the 
visualization mitochondria.  
Mitochondrial movement was observed in C2C12 cells using an expression vector 
that encodes a fusion of red fluorescence protein and the mitochondrial targeting 
sequence from cytochrome c oxidase subunit VIII (mito-dsRED2).  Forty-eight hours 
following transfection with mito-DsRed2, cells were treated with either vehicle (H2O or 
DMSO) or 20mM N-acetylcysteine (NAC) for 60 mins, while incubated with H2O2.  
Mdivi-1 (25μM, Tocris) was used as a selective inhibitor of Drp1, due to its suppression 
of Drp1 GTPase activity, thus blocking the self-assembly of the protein (7).  Imaging of 
Drp1 occurred by transfection of the pEYFP-C1-Drp1 plasmid (Addgene) into myoblasts. 
Mitochondrial Movement Analysis:  Mitochondria were visualized using an inverted 
Nikon Eclipse TE2000-U fluorescent microscope equipped with 100x/1.5 oil objective 
lens, while a custom designed chamber maintained a constant temperature of 37
o
C with 
5% CO2.  Mitochondrial dynamics were captured at 2 sec intervals for a total time of 5 
mins using real-time imaging.  Analyses were performed using the NIS Element AR 3.1 
software, and was limited to regions of interest in the periphery of the cells, where 
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individual mitochondria were readily resolved and could be used for analysis while 
avoiding the confounding influence of high density mitochondrial networks.   
The percentage of time that mitochondria spent in motion with and without the 
addition of H2O2 was determined by monitoring the position of the organelle throughout 
the 5 min capturing time.  Mitochondria were considered in motion if movement was 
greater than 0.01μm in the 2 second capturing frames, and taken as a percentage over the 
5 minute time course for each movie.   
The number of fission and fusion events was determined in a 7x7 μm area over 
the time course of 5 mins.  The average from 3 – 5 squares, placed in a non-overlapping 
fashion, were used to determine the number of fission and fusion events, from 6 – 10 
separate cells.  A fusion event occurred when a mitochondrion extended its projection 
and merged with a neighbouring mitochondrion, and black pixels no longer separated the 
organelles.  Whereas a fission event consist of a break of the mitochondrial filament, 
whereby black pixels separate the once continuous mitochondrial network.   
 Mitochondrial Isolation: Mitochondria were isolated using an adapted protocol 
(6; 17).  Briefly, the medium was removed from myoblasts and washed with ice-cold 
PBS.  Cells were gently scraped in mitochondrial isolation buffer containing 10% 0.1 M 
Tris-MOPS, 1% EGTA-Tris, and 20% 1 M sucrose (pH 7.4).  Subsequently, cells were 
subjected to differential centrifugation and mitochondria were resuspended in 
mitochondrial isolation buffer.  Mitochondrial fractions were used for immunoblotting of 
mitophagy marker proteins. 
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Immunoblotting: Protein extracts from myoblasts and isolated mitochondria fractions 
were separated on 6–12% SDS-PAGE and subsequently transferred onto nitrocellulose 
membranes. Membranes were blocked for 1 hr with a 5% skim milk in 1x TBST (Tris-
buffered saline–Tween-20: 25 mM Tris–HCl, pH 7.5, 1 mM NaCl and 0.1% Tween-20) 
solution at room temperature, followed by incubation in blocking solution with antibodies 
directed towards P-Drp1 (1:250; Cell Signaling), Drp1 (1:500; BD Transduction 
Laboratories), LC3 (1:500; Cell Signaling), p62 (1:5000; Sigma-Aldrich), Porin (1:3000; 
Abcam), mtHSP60 (1:500; Enzo Life Sciences), mtHSP70 (1:1000; Enzo Life Sciences), 
cpn10 (1:500; Enzo Life Sciences), CHOP (1:1000; Cell Signaling), P-eIF2α (1:500; 
Invitrogen), eIF2α (1:500; Cell Signaling), or α-tubulin (1:5000; Calbiochem) overnight 
at 4°C. Subsequently, membranes were washed 3x 5 min with TBST, followed by 
incubation at room temperature (1 hr) with the appropriate secondary antibody 
conjugated to horseradish peroxidase, and washed again 3x for 5 min each with TBST.  
Membranes were developed using Western Blot Luminol Reagent (Santa Cruz), and 
films were subsequently scanned and quantification via densitometric analysis for the 
intensity of signals with SigmaScanPro software (version 5, Jandel Scientific, San Rafael, 
CA, USA).   
Membrane Potential:  Tetramethylrhodamine ethyl ester (TMRE) is a cationic dye that is 
rapidly accumulated by mitochondria due to their ΔΨ.  Depolarization of mitochondria 
results in a decrease in ΔΨ and failure to sequester TMRE.  To determine membrane 
potential, cells were washed 2x with PBS.  Subsequently, cells were incubated with 
TMRE (50 nM, Invitrogen) for 45 minutes.  After washing twice with PBS, the media 
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was replaced with GM without phenol red and imaged.  TMRE fluorescence was 
measured in the dark using a fluorescence microscope at 60X magnification, and light 
exposure was kept to the minimum to insure accurate measurements.  The change in 
fluorescence observed after the addition of H2O2 (300μM) was determined and compared 
relative to untreated cells. The mean from 13-18 cells in 6 separate experiments was used 
for analysis.  
Oxygen Consumption:  Oxygen consumption was determined based on fluorescence 
quenching by oxygen using OxoPlates (Innovative Instruments).  Cells were added to 
each well at a density of 8000 cells/well. The following day, H2O2 (300 μM) was added 
to the wells containing C2C12 cells and oxygen consumption was assessed at 0, 1, 3, and 5 
hrs.  Optical oxygen sensors at the bottom of microplates contained an indicator and a 
reference dye.   Wells containing air-saturated (100%) and oxygen-free (0%) solutions 
were used for calibration.  Fluorescence was assessed for 3.5 hrs in 3 min intervals in 
dual kinetic mode (Synergy HT microplate reader), using filter 1 (530/645 nm) and filter 
2 (530/590) settings in order to detect fluorescence of the indicator and reference dyes, 
respectively.  From these values, ratios were calculated and compared to the standard 
calibrations, thus allowing for quantification of oxygen consumption. 
Statistical Analyses:  Data were analyzed with GraphPad 4.0 software and expressed as 
means ± SE. T-tests and 1-way ANOVAs were performed where appropriate, and 
differences were considered statistically significant if P < 0.05. 
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Results 
Oxidative stress halts mitochondrial movement in C2C12 cells.  We examined the 
influence of oxidative stress on mitochondrial dynamics by live-cell imaging of cultured 
myoblasts. By transfecting mito-dsRED2 to visualize mitochondria (Fig 1A), we 
determined the percentage of time that mitochondria spent in motion, their total path 
length, and the average speed traveled by the organelles.  To analyze the movement 
characteristics of individual mitochondria, kymographs were generated from the live-cell 
imaging videos.  The side-to-side horizontal oscillations visible over the 5 min duration 
of data collection reveal the dynamic properties of the organelles (Fig 1B).  We observed 
that mitochondria remained in constant motion, and frequently changed their direction.  
The addition of H2O2 inhibited mitochondrial movements.  Quantification of organelle 
motility revealed a 44% increase in the percentage of time that mitochondrial remained 
stationary (Fig 1C).  Moreover, H2O2 exposure was able to reduce the total path length 
(above) and the average speed (below) traveled by mitochondria by 31 and 33%, 
respectively (Fig 1D). The reduction in mitochondrial movement is attributed to oxidative 
stress, since the addition of NAC, the free radical scavenger, was able to negate the 
effects observed with H2O2 alone (Fig 1D). 
 
Oxidative stress induces mitochondrial fragmentation, as well as reductions in membrane 
potential and oxygen consumption.  Mitochondrial movement is speculated to be 
associated with alterations in the morphology of the organelle as a result of fission and 
fusion events (Fig 2A).  Thus, we investigated whether oxidative stress would change the 
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frequency of fission and fusion.  Exposure to H2O2 for 5 mins significantly reduced the 
number of fusion and fission events occurring within C2C12 myoblasts by 5.6– and 4.7–
fold, respectively (Fig 2B).  Interestingly, the removal of reactive oxygen species by 
NAC restored the rate of fission, but enhanced the number of fusion events, both in the 
presence and absence of H2O2. 
 At early time points following the addition of H2O2 (1 hr) the morpology of 
mitochondria was not altered (Fig 3A and 3B).  After 3 hrs of exposure, H2O2 resulted in 
an increased percentage of fragmented mitochondria relative to the total area of the cell 
(Fig 3B).  In cells exposed to H2O2 for 5 hrs, the extent of fragmentation was enhanced 
by 3.6–fold (Fig 3B).  These changes in mitochondrial morphology were not due to an 
increase in apoptosis, as cell viability was unaltered up to 5 hrs following the addition of 
300μM H2O2 (unpublished observations). 
Next we sought to determine the functional implications resulting from acute 
exposure to oxidative stress.  H2O2 (300μM) induced membrane depolarization, as 
indicated by reductions in the fluorescence of TMRE, beginning at 1 hr following 
treatment (Fig 3C).  TMRE fluorescence continued to decline to 57% of control values at 
5 hrs.  Since, alterations in membrane potential often result in changes in oxygen 
consumption, we evaluated the effect of H2O2 on C2C12 oxygen consumption at 0, 1, 3, 
and 5 hrs of treatment (Fig 3D).  One hr following exposure to H2O2 (300μM), oxygen 
consumption was reduced by 48%, and continued to decline up to 5 hrs, at which time 
point respiration was reduced by 90% compared to initial values.   
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Oxidative stress-induced mitochondrial fragmentation is mediated by Drp1.  To examine 
the importance of Drp1 during oxidative stress-induced mitochondrial fragmentation, we 
reduced the activity of Drp1 using Mdivi-1.  When myoblasts were exposed to 100μM 
H2O2 for 3 hrs, Mdivi-1 attenuated the amount of fragmented mitochondria by 27% (Fig 
4A).  These findings indicate that Drp1 activation is responsible, in part, for oxidative 
stress-induced mitochondrial fragmentation.  Next, we examined the expression and 
translocation profile of Drp1 following H2O2 exposure.  In control untreated cells, and at 
1 hr following H2O2 exposure, Drp1 was visualized throughout the cytosol, as observed 
by the diffuse yellow fluorescence in the cell (Fig 4B).  Following 3 – 5 hrs of H2O2 
exposure, Drp1 was recruited from the cytosol, concentrated to areas nearby 
mitochondria, and was revealed as an accumulation of Drp1-positive puncta in 
mitochondrial regions (Fig 4B).  Concomitantly H2O2 treatment resulted in the 
dephosphorylation (and activation) of Drp1, which was inhibited by Mdivi-1 (Fig 4C).  
This occurred in the absence of a change in total Drp1 expression.  
 
Acute oxidative stress specifically induces the ER-UPR response, without affecting the 
mt-UPR or mitophagy.  Alterations in mitochondrial morphology have been found to 
correspond to an increased incidence of mitophagy (28).  Thus, we sought to determine 
whether the oxidative stress-induced fragmentation was also affecting mitophagy.  
During 5 hrs of exposure to 300μM H2O2 the levels of the mitophagy markers, LC3 and 
p62 were unaltered in mitochondrial fractions of C2C12 myoblasts.  However, longer 
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treatments with H2O2 (24 hrs) were sufficient to evoke an increase in the localization of 
these mitophagy markers with mitochondrial fractions (Fig 5A). 
To determine whether the mitochondrial-UPR was altered by acute exposure to 
oxidative stress, we examined the expression of mitochondrial chaperones involved in 
protein folding (Fig 5B).  We did not observe any significant changes in the levels of 
mtHSP60, mtHSP70, or cpn10 in either whole cell (Fig 5B) or mitochondrial fractions 
(unpublished observations) by increasing the duration of H2O2 treatment from 1 – 5 hrs.  
We next examined the effects of H2O2 on the expression of ER-UPR proteins.  At 3 hrs of 
H2O2 exposure, a large 12–fold increase in the expression of CHOP was observed, which 
remained elevated at 5 hrs by 8.5–fold relative to control values (Fig 5C).  Similarly, the 
phosphorylation of eIF2α was significantly upregulated by 32% in the presence of 
oxidative stress (Fig 5D). 
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Figure 1: Oxidative stress halts mitochondrial movement in C2C12 myoblasts.  A: 
Representative myoblast co-transfected with mito-DsRED2.  B: The upper panel is the 
first frame in a live-cell imaging series with representative kymographs generated from 
the videos of untreated and treated 300μM H2O2 myoblasts displayed below.  Time (0-5 
min) progresses from the top to bottom in the kymograph.  Whereas, the x-axis represents 
mitochondrial position.  Vertical white lines correspond to stationary mitochondria, and 
horizontal deviations (vibrations from the vertical) depict moving mitochondria. C: The 
percentage of time that mitochondria spent in motion with and without the addition of 
300μM H2O2 was determined by monitoring the position of the organelle throughout the 
5 min capturing time in 10 separate experiments.  D: Quantification of the total path 
length (above) and the average speed (below) traveled by mitochondria was assessed in 
control and 300μM H2O2 treated myoblasts, with or without the presence of N-acetyl 
cysteine (NAC, 60 min pre-treatment).  Movement of mitochondria was determined and 
averaged from n=18 – 80 mitochondria from 6 – 10 separate cells. All values are 
expressed as averages ± SEM, *P < 0.05 vs. CON. 
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Figure 2: Oxidative stress results in changes to mitochondrial dynamics.  A: The first 
frame from a live-cell imaging series of a representative myoblast (centre), with time-
lapse images of myoblasts expressing mito-DsRed2. The left panel displays 
representative images of a 6 sec time-lapse series of a myoblast undergoing 
mitochondrial fission.  The arrows indicate sites of mitochondrial division.  The right 
panel of images displays sequential events of mitochondrial fusion monitored over 19 
secs.  The arrow denotes the extension of a mitochondrial filament, resulting in a fusion 
event. B: The number of mitochondrial fission and fusion events was determined in a 7x7 
μm area over the time course of 5 mins, from 6 – 10 separate cells. The number of fission 
and fusion events was determined in control and H2O2 (300μM) treated myoblasts, with 
or without NAC. Values are expressed as averages ± SEM, *P < 0.05 vs. CON (without 
H2O2 and NAC). 
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Figure 3: Oxidative stress induces mitochondrial fragmentation, as well as 
reductions in membrane potential and oxygen consumption.  Myoblasts were treated 
with 300μM H2O2 for 5 hours, transfected with Mito-dsRED2 for visualization of 
mitochondria and imaged immediately or after 1, 3, or 5 hours of incubation.  
Mitochondrial morphology was assessed as the percentage of the cell occupied by either 
fragmented or network mitochondria.  A: Representative images for each time point 
(top), with magnified images of the mitochondrial network are displayed under each 
condition.  H2O2 altered the morphology of mitochondria, such that more fragmented 
organelles were observed beginning at 3 hrs post-treatment.  B: The percentage (mean ± 
SEM) of total cell area displaying fragmented mitochondria from six separate 
experiments.    C: Membrane potential was analyzed by assessing the fluorescence of 
TMRE. The mean fluorescence intensity of each condition was expressed as a percentage 
of the untreated control. Mean percentage ± SEM of 13-18 cells are shown.  D: O2 
consumption was determined in C2C12 cells treated with 300 μM for a total time of 5 hrs.  
N=4; *Significantly different from 0 hour, P < 0.05. 
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Figure 4: Oxidative stress-induced mitochondrial fragmentation is mediated by 
Drp1.  Mitochondrial morphology for myoblasts expressing mito-DsRed2 after 100μM 
H2O2 exposure.  A: The percentage of fragmented mitochondria were expressed relative 
to the total area of the cells, with (closed bar) or without (open bar) the presence of 
mDivi-1 (25μM, 60 min).  B: C2C12 myoblasts were treated with and without 300μM 
H2O2 for 5 hrs. Cells were co-transfected with Mito-dsRED2 (red) and pEYFP-C1-Drp1 
(green) and imaged at 150x magnification.  Visualization of control myoblasts display 
long, reticular mitochondria with diffuse Drp1.  Whereas H2O2-treatment show small, 
fragmented mitochondria and an accumulation of Drp1-positive puncta concentrated by 
mitochondria, in a time-dependent manner.  The hatched boxes are magnified on the right 
(Insert).  Scale bar represents 10μm.  C: Drp1 dephosphorylation compared to total Drp1 
levels with 100μM H2O2 exposure. The expression of phosphorylated-Drp1 (Ser 637) and 
total Drp1 was assessed with and without 25μM mDivi-1 (60 min pre-incubation).  
*Significantly different from 0 hour, P < 0.05; † significantly difference from untreated 
conditions, P < 0.05; N=6 for each condition. 
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Figure 5: Acute oxidative stress specifically induces the ER-UPR response, without 
affecting mt-UPR or mitophagy proteins.  A: The effect of oxidative stress on 
mitophagy. Representative western blots of the mitophagy protein markers, LC3 and p62, 
were assessed with acute (5 hr) and long exposure (24 hr) with 300μM H2O2 in 
mitochondrial fractions of C2C12 myoblasts. Porin was used as the loading marker.  B: 
Protein expression of markers for the mitochondrial-UPR.  Levels of mtHSP60, 
mtHSP70, and cpn10 protein were determined in whole cell lysates after 300μM H2O2 
exposure.  Tubulin was used as the loading control.  C and D: Representative western 
blots of the ER-UPR markers CHOP, P-eIF2α and eIF2α are displayed above, and 
graphical quantification is depicted below.  Tubulin was unchanged between the 
conditions and was used as a loading control for CHOP.  Values are expressed as 
averages ± SEM.  n=6, *P < 0.05 vs. control. 
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Discussion 
Mitochondria are dynamic organelles, continuously undergoing cycles of fission and 
fusion, resulting in alterations in their morphology and function.  However the 
mechanisms governing these changes have yet to be fully elucidated.  In the current study 
we examined the effects of oxidative stress on mitochondrial motility in myoblasts.  To 
do so, we used live-cell imaging techniques to monitor the dynamics of mitochondria in 
cells with H2O2 exposure.  
Hydrogen peroxide, a major contributor to oxidative damage, was shown to 
induce mitochondrial arrest and time dependent fragmentation.   It was observed initially 
3 hrs after the addition of H2O2, and was further elevated by 5 hrs.  The delay observed 
between the addition of H2O2 and the resulting fragmentation suggests the temporal 
activation of a signaling response, leading to post-translational modifications of Drp1.  
Three hours of H2O2 exposure was associated with a decrease in the phosphorylation 
status of Drp1, thus retaining Drp1 in the cytosol and preventing its translocation to 
mitochondria.  Since Drp1 protein expression was unaltered in the presence of oxidative 
stress, these results indicate that Drp1 is activated by cellular signaling, independent of a 
change in new protein synthesis.  
To validate the importance of Drp1 in oxidative stress-induced mitochondrial 
fragmentation, we inhibited Drp1 dephosphorylation using the selective inhibitor Mdivi-
1. Mdivi-1 administration maintained the levels of P-Drp1, concomitantly with an 
attenuation in H2O2-induced mitochondrial fragmentation.  We observed comparable 
decreases in the number of fission and fusion events 5 mins following the addition of 
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H2O2.  This is consistent with results seen in endothelial cells, whereby similar reductions 
in both fission and fusion were observed with H2O2 treatment, in a dose and time-
dependent manner (21).  Equivalent fission/fusion events have also been measured in 
senescent HUVEC cells (22), and these parallel changes suggest that mitochondrial 
dynamics (ie. fission and fusion) are coordinately regulated.   
Mitochondria were less mobile in cells exposed to oxidative stress.  This 
attenuation in mitochondrial movement was abolished by the addition of NAC, a reactive 
oxygen species scavenger.  Little is known about the factors that contribute to ROS-
mediated mitochondrial immobilization.  We speculated that reduced mitochondrial 
motility could be a consequence of changes in cellular energetics.  Thus, we evaluated 
whether oxidative-stress induced mitochondrial fragmentation and reductions in 
movement coincided with changes in the membrane potential and oxygen consumption of 
the myoblasts.  In corroboration with previous reports (13; 27), our results demonstrate 
that acute exposure to oxidative stress resulted in fragmentation of the mitochondrial 
reticulum within 3 hrs of exposure, an effect that was preceded by a reduction in 
membrane potential and oxygen consumption, beginning after 1 hr of treatment.  Twig et 
al. originally demonstrated that the decreased membrane potential in fragmented 
mitochondria was a prerequisite for mitophagy induction (28).  In addition, Chen et al. 
reported that impaired mitochondrial fusion as a result of Mfn1/2 or Opa1 deficiency 
resulted in lower rates of respiration (10),  resembling the effects found in our H2O2-
treated cells.  Fragmented mitochondrial structures have been observed by others, using 
similar stressful indicators (14; 16; 19; 20; 23).  The resulting fragmented organelles 
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allow for the damaged portions of the mitochondrial network to be isolated from its 
unaffected parts.  Recent findings in HeLa cells have found that mitochondrial fission is 
required for mitophagy induction under oxidative stress (15).  We observed similar 
results in myoblasts, whereby mitochondrial fragmentation preceded an elevation in 
mitophagy.   
Mitochondrial stress is speculated to result in the activation of at least three 
cellular responses, including mitophagy, and the mitochondrial- and ER-unfolded protein 
responses.  The unfolded protein responses are thought to occur prior to the initiation of 
mitophagy.  Here, we show that acute exposure to oxidative stress plays a causal role in 
initiating the ER-UPR without an initial effect on the mt-UPR, indicating the specificity 
of the UPR.  CHOP has been shown to be upregulated by ER stress.  CHOP is a 
transcription factor that binds to and activates the promoter of stress response genes, such 
as c- Jun N-terminal Kinase (JNK) (18).  As such, it is capable of propagating the UPR 
signal.  Additionally, it is also known that CHOP activates the transcription of mtUPR 
chaperone genes, such as mtHSP60 (24).  We observed an increase in the expression of 
CHOP with oxidative stress, despite no changes in the levels of mtHSP60.  Our acute 
treatment with H2O2 may not have been potent enough to elicit the mt-UPR but was 
sufficient to evoke the ER-UPR, in a time-dependent manner.  The ER is responsible for 
the proper folding of vastly more proteins than that of the mitochondrion, and as a result 
may be under more stringent control of the protein folding environment. 
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Figure 6:  Summary and working hypothesis on the effects of ROS.  Increased ROS 
results in reductions in membrane potential (left).  Subsequently, the ROS-induced 
decreases in membrane potential lead to reductions in respiration, as well as enhanced 
mitochondrial fragmentation, mediated by Drp1.  Previous work has shown that 
inhibition of respiratory components results in enhanced organelle fission.  Moreover, 
these changes in mitochondrial morphology lead to increases in the ER-unfolded protein 
response, which then activates mitophagy and the upregulation of the mitochondrial-
unfolded protein response. 
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Our findings indicate that elevated ROS lead to a reduction in membrane 
potential, an event that preceded mitochondrial fragmentation.  Subsequently, the ROS-
induced decrease in membrane potential lead to reductions in respiration, as well as 
enhanced mitochondrial fragmentation.  It is conceivable that reductions in respiration 
result in enhanced fission (Fig 6).  Previous work has demonstrated that inhibition of 
electron transport and ATP synthase induces mitochondrial fission and the formation of 
small, round mitochondria (12).  We demonstrated that the mitochondrial fragmentation 
induced by oxidative stress is mediated, in part, by Drp1.  Moreover, these changes in 
mitochondrial morphology lead to increases in the ER-unfolded protein response, which, 
when persistent, can lead to mitophagy and the activation of the mitochondrial unfolded 
protein responses. 
 In summary, our data indicate that oxidative stress is a vital signaling mechanism 
in the regulation of mitochondrial morphology and motility in myoblasts.  ROS have 
been implicated in several processes underlying the aging process.  Elevated levels of 
ROS can damage DNA, proteins, and lipids (2), and play a key role in the age-related 
tissue dysfunction observed.  Moreover, during aging an increased incidence of 
mitochondrial fragmentation has been observed, with a concomitant increase in the 
expression of mitochondrial fission proteins (19).  Our data suggest that enhanced ROS 
production may underlie the mitochondrial dysfunction and fragmentation observed 
during the aging process. 
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DISSERTATION SUMMARY 
 
 
Classic textbook depictions of mitochondria portray these organelles to be static bean-
shaped structures.  However the mitochondrial population is quite heterogeneous, and 
cells they can form small individual organelles or extended reticula throughout muscle.  
This morphological plasticity is controlled by fission and opposing fusion events.  Our 
laboratory and others (3) have found that chronic muscle use affects the morphology of 
mitochondria, such that as the mitochondrial content increases, so too does the 
occurrence of reticular structures.  In contrast, chronic muscle disuse, induced through 
denervation, has been shown to reduce mitochondrial content, and organelle size (1; 4).  
Similar results have been observed with age, whereby mitochondrial volume density 
decreases with age without a change in organelle number (5), reflecting greater 
mitochondrial fragmentation.  This implies that mitochondrial fission and fusion 
machinery components are involved in regulating the architecture of the organelle during 
muscle disuse.  However the influence that oxidative capacity has on the expression of 
these proteins has yet to be thoroughly investigated.  In Manuscript #1 we examined the 
expression of the proteins that regulate mitochondrial morphology and electron 
micrographs of their structures during conditions of altered oxidative capacity.  We 
hypothesized that chronic activity would induce changes in the expression of 
mitochondrial fission and fusion machineries, such that fusion protein expression would 
outweigh the expression of fission machinery components; conversely we speculated that 
chronic disuse would favour the expression of fission protein components. We first 
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assessed the steady state expression of mitochondrial morphology proteins within fibre 
types of different oxidative capacities.  We observed that the FTR and STR fibres 
possessed the highest expression of both fission and fusion proteins, compared to FTW 
fibres, suggesting more rapid mitochondrial turnover in highly oxidative fibres.  To evoke 
mitochondrial biogenesis and to assess the effects of muscle use, animals underwent 
chronic contractile activity.  To validate that mitochondrial biogenesis occurred with 
CCA we assessed COX activity, a marker of mitochondrial content.  With CCA, 
mitochondrial content increased, and the organelles became reticular in size, along with 
concomitant increases in the fusion proteins.  Next, we induced muscle disuse through 
denervation for 7-days.  We observed fragmented mitochondria following denervation, 
along with significant decreases in mitochondrial content and the expression of fusion 
proteins.  To elucidate the role that aging has on mitochondrial morphology, young (5 
month) and aged (35 month) Fisher 344 Brown Norway rats were used.  Aged animals 
also possessed smaller, fragmented mitochondria.  However, the expression pattern of 
morphology machinery differed between aging and denervation, since aged animals 
displayed an increased expression of the fission proteins.  This study provides us with an 
understanding of how mitochondrial morphology protein expression varies in response to 
altered organelle biogenesis.   
We next examined the regulation of mitochondrial movement within muscle cells 
for Manuscript #2.  Our focus was to determine which cytoskeletal elements were 
responsible for mitochondrial movement within myoblasts.  A live-cell imaging approach 
was used, where we fluorescently labelled mitochondria, allowing us to visualize their 
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movement within myoblasts.  The cells were exposed to microtubule and actin stabilizing 
and destabilizing agents in order to establish which cytoskeletal element is primarily 
responsible for mitochondrial movement within skeletal muscle cells.  We found that 
microtubule disruption resulted in the greatest decreases to mitochondrial speed and path 
length.  We next targeted the microtubule motor proteins, Kif5B and dynein, and reduced 
their protein expressions.  Down-regulation of Kif5B and dynein resulted in similar 
decreases in the average speed of mitochondrial movements, as well as in the total path 
length travelled by the organelles.  In neurons, displacement of mitochondria is regulated 
by calcium, whereby mitochondrial movements are inhibited through the microtubule 
motor protein adapter, Milton.  We investigated the influence that Milton has on calcium-
induced mitochondrial movement.  We observed decreases in mitochondrial speed of 
movement under high calcium conditions, and this effect was negated in cells pre-treated 
with Milton siRNA, suggesting that Milton is involved in mediating mitochondrial arrest 
in the presence of Ca
2+
 in muscle cells.  This study provides an understanding of 
mitochondrial movements and the signalling events that regulate their dynamics, 
allowing us to elucidate the underlying basis for organelle interactions. 
Our laboratory has demonstrated that oxidative stress increases under conditions 
of chronic muscle disuse (1) and aging (2).  Our purpose for Manuscript #3 was to 
determine the influence that oxidative stress would have on mitochondrial dynamics and 
to establish the interplay between mitochondrial morphology and stress responses during 
conditions of oxidative stress.  Once again we used live-cell imaging techniques to visual 
mitochondria over time. We found that oxidative stress halts mitochondrial movement 
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and induces mitochondrial fragmentation in myoblasts.  The observed oxidative stress-
induced mitochondrial fragmentation is mediated by Drp1.  Moreover, we demonstrated 
that unfolded protein responses are activated prior to the initiation of mitophagy during 
oxidative stress.  This study determined that oxidative stress is a vital signalling 
mechanism in the regulation of mitochondrial morphology and motility in myoblasts. 
The overall goal of this Dissertation was to understand the molecular signaling 
and the proteins involved in mediating mitochondrial dynamics in skeletal muscle.  Both 
in vivo and cell culture studies were employed to address this goal.  Specifically, these 
Manuscripts will 1) further our understanding of the role of mitochondrial morphology 
during conditions altered organelle biogenesis, 2) provide insight into the cytoskeletal 
regulation of the mitochondrial movement in muscle cells, and 3) elucidate some of the 
signalling mechanisms governing mitochondrial movement.  Further knowledge into 
these areas will help us understand the molecular basis of mitochondrial dynamics (ie. 
fission, fusion, and movement) during conditions of increased (eg. exercise) or decreased 
(eg. aging) organelle biogenesis. 
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FUTURE WORK 
 
 
1. Does AMP-activated kinase (AMPK) signaling alter mitochondrial dynamics in 
muscle cells? 
  Major signaling pathways that regulate mitochondrial content in skeletal muscle 
include AMPK, calcium, and ROS.  This Dissertation examined the effects of calcium 
and ROS signaling on mitochondrial dynamics, however the influence of AMPK has yet 
to be explored.  The activation of AMPK could be achieved by the addition of AICAR to 
C2C12 myoblasts.  To determine whether AICAR successfully activated AMPK, the 
phosphorylation of AMPK at the Thr
172 
and downstream targets (i.e. ACC) could be 
assessed.  Live-cell imaging techniques could be used to monitor the movement of 
mitochondria in order to elucidate whether organelle motility is affected by AMPK 
activation.   
 
2. Are mitochondrial dynamics altered during myoblast differentiation? 
Mitochondria undergo drastic alterations during myogenesis to meet the increased 
requirements of the cell, including the enhanced level of energy consumption by 
myotubes. The process of differentiation, from myoblast to myotubes, involves 
phenotypic modification not only in the whole cell, but also in their mitochondria.  It is 
known that mitochondria form a dense network when they form myotubes, but their 
motility has never been analyzed.   
The time periods at which differentiation could be examined are the myoblast, 
early, and late myotube formation phases.  These time periods correspond to 
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approximately day 0, 3, and 5 of differentiation.  Whole cell lysates would be collected at 
the same time periods to ensure that mitochondrial biogenesis takes place, using 
cytochrome c oxidase activity as an indicator.  In addition, Mfn2, Opa1, Fis1 and Drp1 
protein expression levels could be assessed at the three periods that we identified.  This 
would allow us to relate mitochondrial movements with the expression of proteins 
involved in organelle dynamics during mitochondrial biogenesis. 
 
3. Can ROS-induced mitochondrial fragmentation be offset by Drp1 inhibition 
under conditions of high ROS production?  
   
ROS have been implicated in several processes underlying the aging process.    
Moreover, during aging an increased incidence of mitochondrial fragmentation has been 
observed, with a concomitant increase in the expression of mitochondrial fission proteins.  
Thus, by inhibiting a key mitochondrial morphology regulator, Drp1, we propose that 
fragmentation would be reduced and the mitochondrial network can be maintained.  
We would examine this question by pre-injecting aged animals with mDivi1, a Drp1 
inhibitor, and determine the changes to mitochondrial morphology by measuring 
mitochondrial morphology protein expression and using electron microscopy.  Moreover, 
the quality of the organelle could be elucidated by measuring COX activity and 
respiration in mitochondria.  
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APPENDICES 
 
APPENDIX A: 
1.0   Additional data 
 
APPENDIX B: 
2.0  Laboratory Methods 
 
 
APPENDIX C: 
3.0  Additional Contributions 
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Introduction 
Mitochondral morphologies vary from interconnected networks to separate punctate 
structures.  Chronic muscle use has previously been shown to increase the mitochondrial 
network (2), whereas chronic disuse induced through denervation has been shown to 
reduce mitochondrial size (1; 3).  Similar results have been observed with age, whereby 
mitochondrial volume density decreases with age (4).  We sought to investigate whether 
the proteins that regulate mitochondrial morphologies where altered as a result of chronic 
muscle use and disuse within whole muscle samples and within mitochondrial 
subfractions. 
 Furthermore, we were also interested in the effects of p53 ablation on 
mitochondrial morphology, since compromised levels of p53 have previously been 
shown to result in an irregular mitochondrial architecture (5).  Mitochondrial morphology 
is closely integrated with mitophagy.   We sought to determine the role of p53 in 
regulating mitophagy within skeletal muscle.   
 Finally, we developed an assay that allowed us to examine the movement of 
organelles within myoblasts, in particular mitochondria, lysosomes, and nuclei.   
Organelles transport was analyzed relative to their size, to assess whether movement is 
dependent on organelle area. 
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Figure 1:  The effect of chronic contractile activity (CCA), denervation (DEN), and 
aging on mitochondrial morphology proteins.  A:  After 7-days of CCA the tibialis 
anterior muscle was extracted from the stimulated and control limbs, and used for 
Western blotting (n = 8).  B)  Mitochondrial morphology protein levels in CON and DEN 
whole muscle were assessed following 7-days of denervation (n = 8-9).  C:  Fission and 
fusion morphology protein expression in young and aged muscle were measured.  Young 
(5 month) and aged (35 month) animals were used.   Representative images of Fis1, 
Drp1, Opa1, Mfn2 protein content (top), with graphical quantification (bottom, n = 6). T-
tests were used for statistical analyses (*P < 0.05).  Expression of the morphology 
proteins was corrected using the loading control Aciculin, and expressed as fold over 
young.   
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Figure 2:  Alterations in mitochondrial morphology proteins with denervation at 3- 
and 7-days.  Mitochondrial morphology protein levels in CON and DEN mitochondrial 
fractions measured for A) Drp1, B) Fis1, C) Opa1 and D) Mfn2 morphology protein 
expression.  Representative images of Fis1, Drp1, Opa1, Mfn2 protein content (top), with 
graphical quantification (bottom, n = 8-9). 1-way ANOVAs were used for statistical 
analyses (*P < 0.05).  Expression of the morphology proteins was corrected using the 
loading control Porin, and expressed as fold over control.   
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Figure 3:  Alterations in mitochondrial morphology proteins with chronic 
contractile activity and aging.  Young (5 month) and aged (35 month) animals were 
used.  After 7-days of CCA the tibialis anterior muscle was extracted from the stimulated 
and control limbs, and used for Western blotting.  A) Fis1, B) Drp1, C) Opa1, and D) 
Mfn2 protein levels were determined in chronically stimulated whole muscle fractions (n 
= 8-13). Representative Western blots are shown for each indicated protein and its 
respective loading controls, with graphical quantification depicted below.  Expression of 
the morphology proteins was corrected using the loading control Porin.  One-way 
ANOVA tests were used for statistical analyses (*P < 0.05).   
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Figure 4: Electron micrographs of skeletal muscle from A) wild type (WT) and B) 
p53 knock out (p53 KO) mice.  Morphological alterations in mitochondria are 
visualized by the representative images taken at a magnification of 7000X and 30, 000X 
(below).  SS mitochondria are shown in the left panel, and IMF mitochondria appear to 
the right.  C) Quantification of the maximal depth of the SS layer and D) the total area 
occupied by IMF mitochondria in 4 μm2 area (n=4-7; *P < 0.05 vs WT). 
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Figure 5: Fission and fusion morphology protein expression in WT and KO p53 
muscle.  A) Representative images of Fis1, Drp1, Opa1, Mfn2 protein content (top), and 
B) graphical quantification (bottom) expressed as fold over WT in SS mitochondrial or 
cytosolic fractions.  Fis1, Opa1 and Mfn2 were determined using SS mitochondrial 
fractions, and corrected using the loading control Portin, whereas Drp1 was assessed in 
cytosolic fractions and corrected using GAPDH  (n=4, *P < 0.05 vs WT).   
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Figure 6:  Expression of key autophagy and lysosomal markers from skeletal muscle 
of WT and KO p53 animals.  A)  Representative Western blots are shown for Beclin1, 
ULK1 and ATG7 from cytosolic fractions.  B) Graphical quantification of each indicated 
protein depicted below (n=4, *P < 0.05 vs WT).   Expression of Beclin1, ULK1, and 
ATG7 was corrected using the Poneau loading control and expressed as fold over WT. 
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Figure 7:  Effects of p53 depletion on mitophagy.  Parkin, p62, LC3II and NIX were 
assessed by immunoblotting.  A)  Representative Western blots are shown for Parkin, 
p62, LC3II, and NIX from mitochondrial and cytosolic subfractions.  Samples were 
corrected for loading using the ponceau and Porin, for cytosolic and SS mitochondrial 
fractions, respectively.  B) Graphical quantification of each indicated protein depicted 
below (n=4–8, *P < 0.05 vs WT).  C)  Representative Western blots are shown for 
LAMP2 and Cathepsin D from cytosolic fractions. 
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Figure 8:  Organelle movement in C2C12 cells.  A) The average velocity, B) area, and 
C) velocity/area of mitochondria, lysosomes and nuclei. * significantly different from 
mitochondria, from 7 separate experiments.  
 
Mitochondria Lysosomes Nuclei
0.0
1.0
2.0
3.0
4.0
5.0
6.0
*
*
A
v
er
ag
e 
V
el
o
ci
ty
( m
m
/s
) 
[x
1
0
0
]
Mitochondria Lysosomes Nuclei
0
1
2
3
4
5
*V
el
o
ci
ty
 /
A
re
a 
(R
.U
.)
Mitochondria Lysosomes Nuclei
0
5
*
*
150
250
A
re
a
 (
m
m
2
)
†
A
B
C
 168 
References 
 
1. Adhihetty PJ, O’Leary MF, Chabi B, Wicks KL and Hood DA. Effects of 
denervation on mitochondrially mediated apoptosis in skeletal muscle. J Appl Physiol 
102: 1143-1151, 2007. 
 
2. Kirkwood SP, Packer L and Brooks GA. Effects of endurance training on a 
mitochondrial reticulum in limb skeletal muscle. Arch Biochem Biophs 255: 80-88, 
1987. 
 
3. Miledi R and Slater CR. Some mitochondrial changes in denervated muscle. J Cell 
Sci 3: 49-54, 1968. 
 
4. Orlander J, Kiessling KH, Larsson L, Karlsson J and Aniansson A. Skeletal 
muscle metabolism and ultrastructure in relation to age in sedentary men. Acta Phyiol 
Scand 104: 249-261, 1978. 
 
5. Saleem A, Adhihetty PJ and Hood DA. Role of p53 in mitochondrial biogenesis 
and apoptosis in skeletal muscle. Physiol Genomics 37: 58-66, 2009.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 169 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX B 
2.0 LABORATORY METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 170 
2.1  MITOCHONDRIAL ISOLATION FROM SKELETAL MUSCLE 
References:  Cogswell et al. Am J Physiol, 1993, 264: C388-C389 
                   Krieger et al. J Appl Physiol, 1980, 48: 23-28 
 
 
Reagents  
All buffers are set to pH 7.4 and stored at 4 °C  
 
- Buffer 1       - Buffer 1 + ATP  
100 mM KCl       Add 1 mM ATP to Buffer 1  
5 mM MgSO4  
5 mM EDTA  
50 mM Tris base  
 
- Buffer 2      - Resuspension medium  
100 mM KCl       100 mM KCl  
5 mM MgSO4      10 mM MOPS  
5 mM EGTA       0.2% BSA  
50 mM Tris base  
1 mM ATP  
 
- Nagarse protease (Sigma, P-4789) 
10 mg/ml in Buffer 2  
Make fresh for each isolation, keep on ice  
 
Procedure  
 
1. Remove the tibialis anterior (TA) muscle from the rat, and put it in a beaker 
containing 5 ml Buffer 1, on ice immediately.  
2. Place TA on a watch glass that is also on ice and trim away fat and connective 
tissue. Proceed to thoroughly mince the muscle sample with forceps and scissors, 
until no large pieces are remaining.  
3. Place the minced tissue in a plastic centrifuge tube and record the exact weight of 
tissue.  
4. Add a 10-fold dilution of Buffer 1 + ATP to the tube.  
5. Homogenize the samples using the Ultra-Turrax polytron with 40% power output 
and 10 s exposure time. Rinse the shaft with 0.5 ml of Buffer 1 + ATP to help 
minimize sample loss.  
6. Using a Beckman JA 25.50 rotor, spin the homogenate at a centrifuge setting of 
800 g for 10 min. This step divides the IMF and SS mitochondrial subfractions. 
The supernate will contain the SS mitochondria and the pellet will contain the 
IMF mitochondria. 
SS mitochondrial isolation:  
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7. Filter the supernate through a single layer of cheesecloth into a second set of 50 
ml plastic centrifuge tubes.  
8. Spin tubes at 9000 g for 10 min. Upon completion of the spin discard the 
supernate and gently resuspend the pellet in 3.5 ml of Buffer 1 + ATP. Since the 
mitochondria are easily damaged, it is important that the resuspension of the 
pellet is done carefully.  
9. Repeat the centifugation of the previous step (9000 g for 10 min) and discard the 
supernate.  
10. Resuspend the pellet in 200 μl of Resuspension medium, being gentle so as to 
prevent damage to the SS mitochondria. Some extra time is needed during this 
final resuspension to ensure the SS pellet is completely resuspended.  
11. Keep the SS samples on ice while proceeding to islolate the IMF subfraction.  
 
IMF mitochondrial isolation: 
7. Gently resuspend the pellet (from step 6) in a 10-fold dilution of Buffer 1 + ATP 
using a teflon pestle.  
8. Using the Ultra-Turrax polytron set at 40% power output, polytron the 
resuspended pellet for 10 s. Rinse the shaft with 0.5 ml of Buffer 1 + ATP.  
9. Spin at 800 g for 10 min and discard the resulting supernate.  
10. Resuspend the pellet in a 10-fold dilution of Buffer 2 using a teflon pestle.  
11. Add the appropriate amount of nagarse. The calculation for the appropriate 
volume is 0.025 ml/g of tissue. Mix gently and let stand exactly 5 min.  
12. Dilute the nagarse by adding 20 ml of Buffer 2.  
13. Spin the diluted samples at 5000 g for 5 min and discard the resulting supernate.  
14. Resuspend the pellet in a 10-fold dilution of Buffer 2. Gentle resuspension is with 
a teflon pestle.  
15. Spin the samples at 800 g for 10 min. Upon the completion of the spin, the 
supernate is poured into another set of 50 ml plastic tubes (on ice), and the pellet 
is discarded.  
16. Spin the supernate at 9000 g for 10 min. The supernate is discarded and the pellet 
is resuspended in 3.5 ml of Buffer 2.  
17. Spin samples at 9000 g for 10 min and discard the supernate.  
18. Gently resuspend the pellet in 300 μl of Resuspension medium.  
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2.2  BRADFORD PROTEIN ASSAY 
 
References:  Bradford M.M et al. Anal Biochem, 1876, 72:248-254 
 
 
PROCEDURE 
 
Reagents 
 
- Extraction buffer 
 100 mM Na/K PO4 
 2 mM EDTA 
 pH to 7.2 
 
- 5 X Bradford dye 
 250 ml 85% Phosphoric acid 
 250 ml 100% Ethanol 
 500 ml ddH2O 
 0.235 g Coomassie Brilliant Blue G250 
 
- Bovine Serum Albumin (BSA) 
 2 mg/ml in ddH2O 
 
Procedure 
 
1. Prepare the test tubes allowing for duplicates of each sample. 
2. Add 95 µl of extraction buffer to each tube. 
3. Add 5 µl of sample to each tube containing the extraction buffer. 
4. To generate the standard curve, add the following volumes (in µl) of extraction 
buffer: BSA, each in separate tubes – 100:0, 95:5, 90:10, 85:15, 80:20, 75:25. 
5. Pipette 5 ml of 1 X Bradford reagent into each tube and mix by gentle vortexing. 
6. In duplicate, add 0.2 ml of each test tube to 96 well plate wells. 
7. Measure absorbance of wells at 595 nm with a microplate reader. 
8. Calculate the protein concentration of each sample using the standard curve.   
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2.3 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
 
PROCEDURE 
 
Prepare electrophoresis rack: 
 
1) Clean glass plates thoroughly with soap followed by acetone, then distilled 
water.   
2) Dry carefully with paper towel without touching surface. 
3) Clean combs and glass plates 
4) Assemble glass plates as shown: 
5) Check the seal by adding a small volume of dH2O then pour this off and 
let dry. 
 
Prepare Separating Gels:  
 
A. Mini PROTEAN 3 BIO-RAD SYSTEM 
 
B. Mix the contents of the separating gel as described above without adding APS 
or TEMED, stir. 
C. Add APS and TEMED, stir. 
D. Slowly pour the entire volume from the beaker into the slot between the 
plates, keeping the plates tilted on an angle to prevent bubbles from forming. 
E. Add tert-Amyl alcohol to cover the top of the gel.  
F. Allow ~30 min for polymerization. 
G. Remove tert-Amyl alcohol by pouring it off quickly, and remove the 
remainder with a kimwipe. Rinse thoroughly with dH20. 
 
 
 
 
 
 
 
 
 
 8 % 10 % 12 % 15 % 18 % 
Acrylamide 2.7 ml 3.3 ml 4.0 ml 5.0 ml 6.0 ml 
Water 4.1 ml 3.5 ml 2.8 mL 1.8 ml 0.8 ml 
Under Tris 3.0 ml 3.0 ml 3.0 ml 3.0 ml 3.0 ml 
SDS 100 µl 100 µl 100 µl 100 µl 100 µl 
APS 100 µl 100 µl 100 µl 100 µl 100 µl 
TEMED 10 µl 10 µl 10 µl 10 µl 10 µl 
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Prepare stacking gel: 
              
1)  
 Mini Gel 
(Volume/Gel) 
Acrylamide 500 µl 
Above Tris buffer 625 µl 
ddH2O 3.75 ml 
SDS 50 µl 
APS 50 µl 
TEMED 7.5 µl 
 
2) Mix the contents of the stacking gel without adding APS or TEMED, stir. 
3) Add APS and TEMED, stir. 
4) Using a pasteur pipette slowly pour the entire volume from the beaker into 
the side of the plates. 
5) Add combs. 
6) Allow approximately 30 min for polymerization. 
 
Prepare samples: 
 
1) Turn on block heater to 95C. 
2) Mix each sample with 2X Buffer and sample dye  
3) Briefly spin each sample to bring the volume to bottom of tube. 
4) Incubate each sample at 95C for 5 min in a heating block to denature the 
proteins. 
5) Briefly spin again to bring the volume to the bottom of the tube, quick 
cool on ice.   
 
Sample Application: 
 
1) Add electrophoresis buffer ensuring that bottom of plates are well 
covered. 
2) Place the gel inside the chamber on bottom support of electrophoresis 
chamber. 
3) Clamp the gel plates to the electrophoresis chamber.  If you are only 
running 1 gel, a rectangular plastic plate must be clamped on the side of 
the chamber opposite to the gel side.  
4) Remove air bubbles using a 5 ml syringe. 
5) Add electrophoresis buffer in the top of the rack. 
6) Remove the comb slowly and evenly using 2 hands from both sides and 
fix any lanes, which have been deformed using a small spatula. 
7) With a kimwipe remove debris from the top of the plates, and clean out 
wells using a pipette. 
8) Withdraw the entire volume of the sample into the pipette tip.  Add it   
slowly into the well, injecting the sample. 
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Gel electrophoresis: 
 
  *Immediately following sample application: 
1) Put the cover(s) on gel chamber. 
2) Turn on power supply (Indicator should be set to measure Voltage not 
current) For small gels: Use 80-120V. 
3) When the sample dyehas run to the bottom of the gel, the run is over.  
Turn off the power supply and remove the electrodes. 
4) Remove the plates carefully from the gel and cut off a corner of the gel to 
remember the gel orientation. The gel is now ready for electrotransfer of 
proteins. 
 
Procedure 
 
1) Remove electrophoresis plates from chamber and separate the plates. 
2) Cut away unnecessary parts of the gel using a spatula, then measure the size 
of the gel that remains. 
3) Using a paper cutter cut 6 pieces of Whatman paper to the exact dimensions of 
the gel. Wearing gloves also cut a piece of nitrocellulose membrane to the 
dimensions of the gel. 
4) Assemble the apparatus as shown: 
 
Transfer Procedure 
 
1) Insert the positive and negative plugs into the jacks of the electroblotter.  Then 
plug the leads into the correct locations of the power supply.   
2) Turn the power on and set to constant voltage. Transfer for 1.5 hr at 100 mA 
(for 8.4 x 6 cm gel).  This may vary depending on the size of the protein of 
interest. 
 
Removal of Transfer Membrane   
 
1) Turn off the power supply, disconnect the negative and positive leads from the 
power supply, and remove the leads from the electroblotter. 
2) Using gloves, carefully remove the Whatman papers, gel slab and transfer 
membrane to a plastic container. 
3) Place the membrane in ddH2O water to rinse.  
4) Add Ponceau S stain and briefly rotate. Save the Ponceau S for reuse. 
5) Rinse each blot thoroughly with ddH2O water to decrease the red background. 
(If the membrane is to be cut, it should be done now while protein bands are 
visible). 
6) Wrap in saran wrap and scan membrane.  
7) Rotate membrane in Wash Buffer until the remaining Ponceau S stain is 
removed. 
8) Incubate membrane with blocking solution for 60 min at room temperature 
with gentle rotation. 
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9) Incubate membrane with appropriate antibody diluted in blocking solution 
overnight at 4C.  Membrane is placed face up on a glass plate that has been 
covered with parafilm.  The antibody is applied to membrane.   
 *Note: To maintain a moist environment during an overnight incubation, wet 
a small Kimwipe and form it into a ball and placed on any corner of the plate.  
The plate is covered over with a heavy object over a plastic container.   
 
Immunodetection 
 
1) Wash with rotation 3 X 5 min in Wash Buffer. 
2) Incubate membrane 60 min with appropriate secondary antibody diluted in 
blocking solution.  *Note: The membrane is placed face-up onto the glass 
plate, which is covered with parafilm.  The antibody diluted in blocking 
solution is applied to the face of the blot, covered in saran wrap. 
3) Wash with rotation 3 X 5 min in Wash Buffer. 
  
Enhanced Chemiluminescence Detection  
 
 1)  Mix ECL fluids 1:1 ratio. 
2) Apply fluid to blot and leave for 2 min. 
3) Drip off the excess and place in saran wrap. 
4) Expose blot to film (time will vary) 
5) Develop while clipped to metal film holder (time will vary). 
6) Fix for 2 min. 
 
Stripping blots and re-probing 
 
1) Pre-heat the rotating incubator to 50C. 
2) Place one previously probed membrane in a small hybridization tube with 20 
mL of Stripping Solution.  Wash in rotating incubator for 30 min at 55C.  
3) Wash membrane 3 x 10 min in wash buffer. The blot can now be blocked. 
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SOLUTIONS 
 
1. Polyacrylamide Solution 
   30% (w/v) Acrylamide  
  0.8% (w/v) Bisacrylamide  
  Filter using 15 cm Whatman circular filter paper. 
  Store at 4C  
 For 400 ml: Using gloves, measure out 120 g of acrylamide and 3.2 g of 
bisacrylamide and volume up to 400 ml with dH2O.  Suction filter. 
 
2. Under Tris Buffer   
  1 M Tris-HCl pH 8.8 (60.5 g /500 ml) 
 
3.    Over Tris Buffer 
  1 M Tris-HCl, pH 6.8   (12.1 g /100 ml) 
  Bromphenol Blue (for colour) 
  Store at 4C  
 
4. Ammonium Persulfate (APS) 
  10% (w/v) APS in ddH2O (1 g/10ml) 
  store at 4C 
  
5. Sodium Dodecyl Sulfate (SDS) 
  10% (w/v) in ddH2O (1 g/10ml) 
  Store at room temperature. 
  
 6. TEMED 
  
7. Electrophoresis Buffer pH=8.3 (10 L) 
  25.0 mM Tris   30.34 g 
  192.0 mM Glycine     144 g  
  0.1% (w/v) SDS        10 g 
  8. 6X SDS Sample Dye  (10 ml; store in 1ml aliquots at -20C) 
  1M Tris (pH 6.8) 3 ml 
  DTT   0.926 g 
  Bromophenol Blue  0.06 g 
  100 % glycerol 6 ml 
  SDS   1.2 g 
  dH20   1 ml 
 
 9. tert-Amyl alcohol, 99% 
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REAGENTS 
1. Transfer buffer 
0.025M Tris HCl, pH 8.3 6.057 g 
0.15M Glycine 22.52 g 
20% MeOH 400 ml 
    
*make up to 2 L with ddH20 
 
2. Ponceau S 
  Dilute contents of bottle up to 150 ml with ddH20. 
 
3. Wash Buffer 
  Tris-HCl, pH 7.5  12 g 
  NaCl     58.5 g 
  0.1% Tween20  10 ml  
            
4. Blocking Solution 
  5% (w/v) Skim Milk in Wash Buffer OR 
  5% (w/v) BSA in Wash Buffer 
 
5. ECL Fluid  
 
6. Film/Developer/Fixer 
 
7. Stripping Buffer (for 1 L) 
 
   
 
 
*volume up to 1 L with ddH2O 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
Tris-HCl, pH=6.8 20 g  
β-mercaptoethanol 7 ml 
SDS 20 g 
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2.4 MITOCHONDRIAL ISOLATION FROM C2C12 MYOBLASTS 
 
References: Frezza et al. Nature Protocols, 2007, 2:287-95 
 
 
SOLUTIONS: 
 
Mitochondrial Isolation Buffer (MIB)  (*make fresh) 
1. 10 ml of 0.1 M Tris-MOPS (store at 0-4°C) 
0.1 M Tris   6.05 g / 500 ml 
pH to 7.4 using MOPS 
 
2. 1 ml  of 0.1 M EGTA/Tris (store at 0-4°C) 
0.1 M EGTA   19.05 g / 500 ml 
pH to 7.4 using Tris 
 
3. 20 ml of 1 M sucrose  (*make fresh) 
1 M sucrose   34.33 g / 100 ml 
 
ISOLATION PROCEDURE: 
 
This final isolation procedure has been determined to be the optimal method for the 
isolation of intact mitochondria from the tissue culture of C2C12 myoblasts through 
differential centrifugation.  The entire procedure is done at 4°C (everything to be kept on 
ice). 
 
1:  Set out materials ( get 2 buckets of ice and chill Teflon pestle and glass potter (15 
ml), centrifugation tubes, 15 ml conical tube, 200 ml of MIB and PBS on ice). 
2:  Remove the 10 cm plates from the incubator, and wash 2x with ice-cold PBS 
(keep plates on ice).  
3:  Add ~1.5 ml of MIB per plate, and quickly and gently scrape the plates with a 
rubber policeman, rotate the plate 45° and re-scrape to ensure all the cells have 
detached.  Transfer the scraped cells into chilled pre-labelled mitochondrial 
isolation tube and keep on ice and cap when done.  If using for mitochondrial 
respiration use a minimum of 10 x 10 cm plates.     
 ---- Repeat this step for each sample ----  
4:   At a centrifuge setting of 600 g, with Beckman JA25.5 ROTOR, spin the samples 
for 10 min.  Discard the supernatant and Resuspend the pellet in 3 ml of ice-cold 
MIB. 
5:    Transfer the suspension into a chilled 15 ml potter.  Homogenize the cells using 
the Potter-Elvehjem PTFE Tissue Grinders at 800 rpm for 35 strokes (~4.5 min).  
Set timer to ensure consistency between samples.   
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6:      Transfer the homogenate to a fresh tube and spin for 10 min at 600g, transfer only 
the supernatant gently through a falcon tube fitted with a 45 um filter, being 
careful to avoid the pellet.   
7:   Collect the supernatant and (contains mitochondria and cytosol) and transfer to a 
clean pre-chilled mitochondrial isolation tube.  Quick spin at 600 g for 3 min to 
ensure that any remaining cellular debris is pelleted, now transfer only the 
supernatant to the last fresh tube. 
8: Centrifuge the supernatant at 9,000 x g for 10 min. at 4
°
C. 
9: Discard the supernatant and the resultant pellet is the mitochondria. 
10:  Gently Resuspend the pellet in 400 µl of M1B and transfer mitochondrial solution 
to a 1.5 ml eppendorf. 
11:   Spin in a microcentrifuge at 9,000 x g for 10 min. at 4°C. 
12:  Discard the supernatant and re-suspend the mitochondria in 80-120 µl of MIB 
depending on mitochondrial yield.  Record the final volume and perform a 
Bradford assay to assess total µg of mitochondrial yield.  
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2.5  RNA ISOLATION 
PROCEDURE: 
 
1) Homogenize (approximately 30 sec. @ 30-40% power) tissues (200 mg) at  
 30% in 2 ml Tri-reagent in a 13 ml Sarstedt tube; 
OR 
Homogenize (approximately 30 sec. @ 30-40% power) tissues (200 mg) at  
30% in 1.25 ml solution D + 1.25 ml phenol + 0.125 ml 2M sodium acetate  
(pH 4.0) in a 13 ml Sarstedt tube 
 
**Note: The homogenizer must be sterilized in 0.1M NaOH and rinsed in 
sterile water prior to use.  Rinse in sterile water between samples. 
 
2) Let stand for 5 min at room temperature; 
 
3) Add 0.4 ml chloroform and shake vigorously for 15 sec, let stand for 2-3 min at 
room temperature; 
 
4) Spin at 12,000 g for 15 min at 4°C; 
 
5) Transfer aqueous phase to 13 ml Sarstedt tube; 
 
6) Add 1 ml isopropanol, gently shake, and allow precipitation of RNA for 5-10 min 
at room temperature; 
 
7) Spin at 12,000 g for 10 min at 4°C; 
 
8) Remove supernatant and add 0.7 ml 75% ethanol; 
 
9) Transfer RNA to eppendorf tube; 
 
10) Rinse 13 ml Sarstedt tube with 0.3 ml 70% ethanol, add to eppendorf tube and 
mix by vortexing; 
 
11) Spin 5 min in eppendorf centrifuge at 4°C; 
 
12) Discard supernatant; 
 
13) Dry pellet under a vacuum in dessicator (DO NOT DRY PELLET WITH 
CENTRIFUGATION UNDER A VACUUM); 
 
14) Dissolve pellet in 50-200 μl sterile distilled DEPC water and measure absorbance 
at 260 nm and 280 nm. 
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REAGENTS: 
 
1. Solution D  (Denaturing solution) 
4 M Guanidinium Thiocyanate     125 g  
25 mM of 1 M stock NaCitrate (pH 7.0)   6.6 ml 
N-Lauroyl Sarcosine;Sigma L-5125 (0.5% Sarcosyl) 1.32 g  
ddH2O        160 ml  
**Note: make up solution D and store at RT for up to 3 months.  On the 
day of the experiment, mix 50 ml of Solution D with 0.36 ml of beta-
Mercaptoethanol (0.1 M b-MEtOH) 
 
2. Phenol (Nucleic acid grade) 
a) Melt solid phenol at 68 
°
C (cap loose) in H2O; 
b) Add 0.25 g 8-hydroxyquinoline to 250 ml of phenol, mix; 
c) Add 250 ml 1.0 M Tris HCl (pH 8.0) and stir overnight at 4 
°
C covered in foil 
d) Remove supernatant;  
e) Add 250 ml 0.1 M Tris-HCl containing 0.2 % b-MEtOH (0.178 ml/100 ml for 
S.G. = 1.12) and mix thoroughly;  
f) Allow solution to settle and remove supernatant; 
g) Repeat 2 more times as above or until pH of phenol is > 7.6 (test with pH paper). 
h) Store in 25-50 ml aliquots at -20 
°
C. 
 
3. 2.0 M Na Acetate (pH 4.0) 
10.88 g/100 ml sterile H2O 
 
4. 75% ethanol in sterile H2O  
(75 ml ethanol + 25 ml dH2O) 
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2.6  REVERSE TRANSCRIPTION, FIRST STRAND cDNA SYNTHESIS 
 
First-strand cDNA synthesis is performed following the manufacturer's 
recommendations that are outlined below: 
 
REAGENTS: 
 
1. total RNA (isolated as described) 
2. Oligo(dT)12-18 
3. 10 mM dNTPs (dATP, dTTP, dCTP, dGTP; 10 mM each) 
4. Sterile ddH20  
5. RNAse OUT (40 units/ µl) 
6. 0.1 M DTT 
7. 5X First-strand Buffer 
8. SuperScript II RT 
 *Note: All reagents except RNA are supplied with the SSII kit from Invitrogen. 
 
 
PROCEUDRE: 
 
1. Add following components to a nuclease/ RNA-free 500 µl eppendorf: 
   Oligo(dT)12-18   1µl 
   1 µg of RNA   x µl 
   dNTP mix    1 µl 
   Sterile ddH20   to 20 µl 
 
2. Heat mixture to 65°C for 5 minutes and quick chill on ice.  Collect the contents 
with a quick spin in a tabletop microcentrifuge and then add: 
   5X First-strand buffer  4 µl 
   0.1 M DTT   2 µl 
   RNAse OUT   1 µl 
 
3. Mix contents of tube gently and incubate at 42°C for 2 minutes. 
4. Add 1 µl (200 units) of Superscript II RT and mix by pipetting gently up and down. 
5. Incubate at 42°C for 50 minutes. 
6. Inactivate the reaction by heating at 70°C for 15 minutes. 
7. cDNA is ready for use in PCR amplification.  
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2.7  POLYMERASE CHAIN REACTION (PCR) 
 
 
1) 2 ug of RNA is converted to 2 ug of cDNA (STOCK cDNA)   
        
2) We dilute STOCK cDNA to 1:30 (2 uL STOCK cDNA added to 58 uL nuclease-free 
ddH₂O) 
 
3) We add 4 μL of diluted cDNA, thus loading 10 μg cDNA per well 
 
4) For SYBR Green analyses, primers were optimized, diluted and mixed with PerfeCTa 
SYBR® Green SuperMix, ROX Master Mix and nuclease-free ddH₂O 
 
5) Total reaction volumes were always 25 μL 
 
6) Samples must be duplicated to ensure accuracy. 
 
7) Use negative wells to monitor contamination, using nuclease-free ddH₂O in place of 
cDNA. 
 
8) Check for nonspecific amplification and primer dimers by analyzing melt curves 
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2.8  WHOLE CELL RESPIRATION WITH OXOPLATE 
 
EQUIPMENT REQUIRED: 
 96-well Flat Bottomed OxoPlate – OP96C  
Manufacturer – PreSens (http://www.presens.de/) 
North American Distributor – Innovative Instruments Inc.  
(http://www.3i-usa.com/) 
 Fluorescence Plate Reader 
 96-well plate sealing film 
 
SOLUTIONS REQUIRED: 
1. 0% O2 Standard 
2. 100% O2 Standard 
3. Growth Media – Phenol Red Free 
 
SOLUTION PREPARATION: 
 Adapted from OxoPlate Manual 
 
 0% O2 Standard: 
1. Add 150mg of sodium sulfite (Na2SO3) to a 15 mL screw top tube. 
2. Add 15 mL of ddH2O and seal tube 
3. Vortex and allow >1 minute for oxygen to be depleted from solution 
Notes: 
 Must use a screw top lid and use enough ddH2O to almost 
entirely fill container. This will minimize any dissolving of 
O2 from the air in the tube. 
 DO NOT REPLACE ddH2O with Growth Media 
 Shelf life is ~24 hours 
 
100% O2 Standard: 
1. Aliquot 25 mL of Phenol Red Free Growth Media into a 50 mL screw 
top tube. 
2. Shake vigorously for 2 minutes. 
3. Loosen screw top and gently rotate tube to decrease foaming and 
prevent oversaturation of solution. 
Notes: 
 Shelf life is ~24 hours 
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PROTOCOL: 
1. Day 1: 
a. All conditions must be performed as a minimum of 3 replicates. 
b. Perform all work in darkness and protect the OxoPlate from light at all 
times. 
c. Plate 8,000 cells/well into wells to be used for experiment. 
i. DO NOT PLATE CELLS IN WELLS FOR STANDARDS 
ii. A sample plan is included below. 
d. Cover plate, protect from light, and incubate 
i. Incubate long enough for cells to adhere (recommended 24 hours) 
 
2. Day 2: 
a. Prepare standards (0% O2 Standard and 100% O2 Standard) 
b. Warm all cell culture media and drugs prior to beginning. 
c. Add 400 μL of standards to at least 3 empty wells per standard. Do not 
allow mixing. 
d. Carefully aspirate all cell culture media from wells containing cells 
e. Add 400 uL pre-warmed Phenol Red Free Growth Media or Phenol Red 
Free Growth Media with drug treatment quickly to each well. 
f. Seal with 96-well plate sealing film 
g. Immediately read on fluorescent plate reader with the parameters listed 
below. 
h. If required, correct for differences in cell number. 
 
 
 
Fluorescence Plate Reader Settings: 
 Reading Type: Kinetic 
 Reader:  Synergy HT-I on: Fluorescence 
 Filer Set: 2 
 Excitation: 530/25 (for both) 
 Emission: 645/40 and 590/35 
 Optics Position: Bottom (for both) 
 Sensitivity: 50 (for both) 
 Click Options (same for both) 
o Nb Samples per Well: 20 – Can decrease reading time by reducing 
this number 
o Delay before Sampling: 300 msec – Can decrease reading time by 
reducing this number 
o Delay between samples: 1 msec 
 Select: Kinetic… 
o Run Time: 03:30:00 
o Click Minimum 
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o Interval should be 00:02:51 with above settings 
o Check Allow Well Zoom during read 
 Temperature Control: Yes 
 Check Pre-Heating 
 Temperature: 37ºC 
 Lag time: 00:00:00 
 Change First and Last well depending on number of wells being used with 
less wells you can go back to the Kinetic… options and click minimum and 
the time interval will reduce. 
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2.9  CYTOCHROME C OXIDASE (COX) ASSAY FOR MICROPLATE READER 
 
 
Cell extract containing cytochrome c oxidase is added to the test solution containing fully 
reduced cytochrome c. The rate of cytochrome c oxidation is measured over time as a 
reduction in absorbance at 550 nm. The reaction is carried out at 30
o
 C. 
 
REAGENTS 
 
1. Horse Heart Cytochrome c (Sigma, C-2506) 
2. Sodium Dithionite 
3. 100 mM K-Phosphate Buffer (KPO4; pH to 7.0) 
-make and mix equal proportions of 0.1 M KH2PO4 and 0.1 M K2HPO4.3H2O 
4. 10 mM K-Phosphate Buffer 
 -dilute 100 mM K-Phosphate Buffer 1:10 with ddH2O 
 
PROCEDURE 
 
1.  Immediately following the completion of the enzyme extraction protocol from 
cells, proceed to making Test Solution.  Add the following to a scintillation vial: 
 
- weigh out 20 mg of horses heart cytochrome c 
- add 1 ml of 10 mM KPO4 buffer and fully dissolve cytochrome c 
- make up a small volume of 10 mg/ ml sodium dithionite- 10 mM KPO4 stock 
solution (Note: make fresh each experiment and use within 20 minutes) 
- add 40 µl of dithionite stock solution to the Test Solution and observe the red to 
orange colour change 
- add 8 ml of ddH2O 
- add 1 ml of 100 mM KPO4 buffer (Note: the Test Solution becomes light sensitive 
at this step; make sure to the cover vial with aluminum foil). 
 
2.   Add 300 µl of Test Solution into 4-8 wells of a 96-well microplate and incubate at 
30°C for 10 minutes to stabilize the temperature and absorbance. 
 
3. Open KC4 plate reader program. Select CONTROL icon, then PRE-HEATING 
tab, enter 30°C and select ON  (Do not run assay until KC4 temperature has 
reached 30°C). 
4.  Set-up of COX activity protocol on computer. 
 
5. Select WIZARD icon, then READING PARAMETERS icon. 
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 Select Kinetic for Reading Type. 
 Select Absorbance for Reader and 550 nm for wavelength (drop-down). 
 Select Sweep for Read Mode. 
 Select 96 Well Plate (default) for Plate Type. 
 Enter first and last well to be read (eg. A1 and A4 if reading 4 samples 
simultaneously). 
 Select Yes and Pre-heating and enter 30 for Temperature Control. 
 For Shaking enter 0 for both intensity and duration (shaking is not 
necessary and it will delay the first reading).  
 Do not select either of the two options for Pre-reading. 
 Click on the KINETIC… rectangular tile to open the Kinetic window. 
 Enter run time (1 minute is recommended) and select MINIMUM for 
Interval time (under these conditions the minimum Interval time should be 
3 seconds). 
 Select Allow Well Zoom During Read to see data in real time (optional). 
 Under Scales, checkmarks should appear for both Auto check boxes.  Do 
not select Individual Well Auto Scaling. 
 Press OK to return to Reading Parameters window.  Press OK to return to 
Wizard window.  Press OK.  Do not save the protocol. 
 
6. Set the micropipette to 225 µl and secure 4-8 tips on the white projections (make 
sure they are on tight and all the same height). 
 
7. In a second, clean 96 well plate, pipette samples into 4-8 empty wells (start with 
A1).  Recommended volumes: 65 µl of enzyme extract from C2C12 cells. 
 
8. Remove microplate with Test Solution from the incubator (as long as it has been 
incubating for 10 minutes).  Place this plate beside the plate with the sample 
extracts in it. 
 
9. On KC4 program, select the READ icon and press the START READING icon, 
then press the READ PLATE button.  A box will appear that says, “Insert plate 
and start reading”.  Do not press OK yet, but move the mouse so that the cursor 
hovers over the OK button. 
 
10. Using the micropipette (set to 225 µl) carefully draw up the Test Solution.  Make 
sure the volume is equal in all the pipette tips, and that no significant air bubbles 
have entered any of the tips. 
 
11. Pipette the Test Solution into the wells with the sample extracts (the second 
plate).  As soon as all the Test Solution has been expelled from the tips (do not 
wait for the second push from the multipipette), place the plate onto the tray of the 
plate reader and with the other hand on the mouse, press the OK button.  (Speed at 
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this point is paramount, as there is an unavoidable latency period between the 
time of pressing the OK button and the time of the first reading.)  
 
12. If desired, add 5 μl KCN to one of the wells to measure any absorbance changes 
in the presence of the CYTOX inhibitor. 
 
13. Once reading is complete, hold the CTRL key on the keyboard, and use the mouse 
to click once on each of the squares corresponding to a well that had sample in it.  
Once all the desired wells have been highlighted by a black square (up to a 
maximum of 8 wells), let go of the CTRL key and a large graph will appear with 
lines on it representing each sample.   
 
14. To obtain the rate of change of absorbance over different time periods, select 
Options and enter the amount of time for which you would like a rate of change of 
absorbance to be calculated.  The graph, along with one rate (at whichever time 
interval is selected) for each sample can be printed on a single sheet of paper, and 
the results can be saved. 
 
15. The delta absorbance will appear in units of mOD/min and the number given will 
be negative.  Convert this to OD/min by dividing by 1000 and omit the negative 
sign in the calculation.  (eg. if Mean V: -394.8 mOD/mn, then use 0.395 OD/min) 
 
 
CALCULATION:   
 
CYTOX activity =  mean dealta absorbance/ minute x total volume (ml) x 1000 
        18.5 (µmol/ml extinction coeff.) x sample volume (ml) x total µg/ well 
 
Example Calculation:  
 
55 µl of enzyme extraction   COX activity = (0.5843)(0.285)(1000) 
230 µl of Test Solution                (18.5)(0.055)(3.023 x 55) 
Mean V: -584.30 mOD/mn 
Protein concentration: 3.023 µg/ µl  COX activity = 0.967 nmol/min/µg protein 
Total µg/ well: 151.15 
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2.10  FURA-2-AM CA2+ IMAGING 
 
 
All the media used is DMEM without phenol red. 
 
1. Wash each chamber 2X with media.  Add 500 uL DMEM without phenol red to 
each chamber. 
 
2. Add 5uL of Fura-2-AM (Invotrogen) and 5uL of pleuronic acid (Invitrogen) to 
1mL of DMEM.  Add 500 uL per chamber and incubate at 37
o
C for 45 minutes.   
 
3. Wash 2X with DMEM, and add fresh media.  Incubate for  20 min to allow de-
esterification to occur i.e. Fura-2AM doesn’t exit. 
 
4. Imaging is carried out by using 340 and 380 excitation filters. 
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